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Stroke is clinically defined by an acute neurological deficit which is best explained by 
either cerebral infarction or intracerebral hemorrhage (ICH).1, 2 Worldwide, stroke is the 
second most common cause of mortality and one of the most common causes of 
disability.3 Stroke most often occurs in patients over 70 years of age, however stroke in 
young adults is a rapidly increasing problem with almost doubling of its proportion in the 
total number of all stroke patients, up to almost 20% over the past decade.4 While there 
is no uniform definition of “young stroke,” strokes occurring in those after adolescence 
(18 years) and before the age of 50 are typically considered as “young strokes”. 
Prognosis
Young stroke occurs in the period of life during which people would like to start  families, 
have to raise children or make decisive career moves. In order to live such a life, patients 
have to regain complex skills after stroke, not only for the months to come, but rather for 
the decades after their stroke. However, there is a lack of reliable information about the 
long-term functional outcome after a stroke in a young adult. The resultant uncertainty 
may have a profound impact on young patients’ choices and planning.
 Short-term prognosis after a stroke at young age is considered more favourable than 
in older patients.5 However, whereas prognosis in patients who develop a stroke at higher 
ages (usually over 70 years) is among the best studied topics in clinical medicine, this does 
not hold true for young stroke. There are some long-term follow-up studies in young 
stroke patients addressing post-stroke mortality, recurrent vascular events and epilepsy.6-9 
However, outcome measures, such as cognitive deficits, quality of life and post-stroke 
functioning were rarely taken into account in these studies. This is striking because when 
asked to identify their top 10 research priorities after stroke, both patient and health-care 
professionals particularly mentioned psychosocial consequences related to life after 
stroke of utmost importance.10 Therefore, in our opinion, it was necessary to increase the 
knowledge on these topics in order to support health professionals in the counseling of 
young stroke patients on the course of their disease. 
 Another, less well studied group within the spectrum of young stroke are transient 
ischemic attack (TIA) patients. The etiology of TIA and ischemic stroke (IS) is similar and the 
distinction between the two can be hard and depends on whether the classic clinical 
World Health Organization criteria (deficits for more or less than 24 hours) or radiological 
criteria (the absence or presence of brain infarction on imaging) are being used. Although 
TIA patients by definition have no residual neurological deficits 24 hours after initial 
symptom onset, it becomes increasingly apparent, based on data from the elderly,11-13 that 
a TIA can lead to cognitive sequelae This information is not available for young TIA patients. 
So, apart from young stroke patients it appears equally important to provide young TIA 
patients with accurate prognostic information. 
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Apart from increasing knowledge about long-term prognosis after young stroke in 
general, it is also needed to identify determinants of prognosis. Those factors do not 
necessarily have to be treatable, information on determinants that can be used to properly 
inform patients and their relatives is equally important. It is most valuable when such 
determinants are available in the weeks to months after a stroke at young age, to give the 
health care professionals the opportunity to provide patients a personalized long-term 
prognosis shortly after a stroke at a young age.
Aim of the thesis and study design
The overall aim of this thesis was to investigate the long-term prognosis after stroke in 
young adults aged 18-50 years, including functional outcome, cognition and quality of 
life. In addition, we specifically aimed to identify which determinants best predicted 
long-term functioning in young stroke patients.
 The studies presented in this thesis are based on two separate young stroke cohorts. 
Chapter 2 and 5 are based on the Follow-Up of Transient ischemic attack and stroke 
patients and Unelucidated Risk factor Evaluation (FUTURE)-study, a prospective cohort 
study that investigates causes and consequences of a young stroke.  The FUTURE study 
comprised all consecutive patients with a TIA, IS or intracerebral hemorrhage (ICH), 
between ages 18 – 50 years, admitted to the Radboud University Medical Center Nijmegen, 
the Netherlands, from January 1, 1980 until November 1, 2010 (n=1005). Exclusion criteria 
were traumatic hemorrhagic stroke, hemorrhage in known cerebral metastasis or primary 
brain tumor, cerebral venous sinus thrombosis, subarachnoid hemorrhage or intracranial 
hemorrhage (ICH) due to known ruptured aneurysm and retinal infarction. Patients alive 
(n=705) were invited for follow-up assessment consisting of questionnaires between 
November 1, 2009 and January 1, 2012. Subsequently, between August 1, 2014 and January 15, 
2015 patients alive were approached by telephone to assess the occurrence of incident 
vascular events and to assess their present ability to function independently in daily life.
 Chapter 3 and 4 are based on a retrospective cohort of 340 young ischemic stroke (IS) 
patients (18-50 years) who presented in the St. Elisabeth Hospital and the TweeSteden 
Hospital, Tilburg, the Netherlands, between January 1st, 2000 and December 31st 2010. 
Patients with a history of previous ischemic stroke were excluded. Follow-up, consisting 
of several questionnaires and a neuropsychological examination, was done between 
April 2011 and June 2011.
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Outline of the thesis
Chapter 2 describes the long-term functional outcome after a young TIA, IS and ICH, 
including risk factors of a poor functional outcome. In chapter 3 we explored which 
stroke-specific, psychological and social factors affect the quality of life in the years after 
a stroke at young age. Chapter 4 reports on the long-term cognitive function after young 
stroke. Chapter 5 provides information on potential determinants of poor outcome after 
young stroke. Information from the previous chapters is combined to analyze whether 
cognitive impairment after a young stroke is a predictor for poor long-term functional 
outcome (section 5.1). Subsequently, we investigated how kidney dysfunction affects the 
risk of mortality and incident vascular events after young stroke (section 5.2). In chapter 6 
and 7 the main results from the studies presented in the preceding chapters are 
summarized and discussed.  We concluded with several recommendations for clinical 
practice and suggestions for future research.

Long-term functional prognosis  
after young stroke
2
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Abstract
Background and purpose: Stroke in young adults has a dramatic impact on life, therefore 
we investigated the long-term functional outcome after transient ischemic attack (TIA), 
ischemic stroke (IS) or intracerebral hemorrhage (ICH) in adults aged 18 through 50 years.
Methods: This study is part of a large cohort study among 722 first-ever young stroke 
patients, admitted to our department between January 1, 1980 and November 1, 2010. 
Functional outcome was assessed by stroke subtype between 2009-2012 with the 
Modified Rankin Scale (mRS) and Instrumental Activities of Daily Living scale (iADL). 
Results: After a mean follow-up of 9.1 (SD8.2) years, 32.0% of all patients had a poor 
functional outcome (mRS>2); for IS this was 36.5%, for ICH 49.3% and for TIA 16.8%. 10.8% 
Of TIA, 14.6% of IS and 18.2% of ICH patients had a poor outcome as assessed by iADL (<8). 
Conclusions: Ten years after IS or ICH in young adults, one out of eight survivors is still 
dependent in daily life.
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Introduction
Approximately 10% of all strokes occur in patients between 18-50 years.1 Uncertainty 
about their long-term functional outcome may affect these young stroke patients’ choices 
and family and career planning. 
 However, only few studies addressed the long-term functional outcome in young 
stroke patients.2-4 None of these included the whole stroke spectrum ranging from 
transient ischemic attack (TIA), ischemic stroke (IS) to intracerebral hemorrhage (ICH). 
 The objective of the present study was therefore to evaluate the long-term functional 
outcome in young stroke patients considering both motor activities and more complex 
daily tasks, after a TIA, IS as well as ICH. 
Materials and methods
This study is part of the “Follow-Up of Transient ischemic attack and stroke patients and 
Unelucidated Risk factor Evaluation”-study (FUTURE study), as described elsewhere.5 
The Medical Review Ethics Committee region Arnhem-Nijmegen approved the study. 
Written informed consent was obtained from all patients.
Patients
The FUTURE study comprised all consecutive patients aged between 18-50 years with a TIA, IS 
or ICH, admitted to the Radboud University Medical Centre Nijmegen, the Netherlands, 
from January 1, 1980 and November 1, 2010. First-ever TIA, IS or ICH patients were included 
in the present study. Patients alive were invited for follow-up assessment between 
November 1, 2009 and January 1, 2012. 
Functional outcome 
The primary outcome was functional outcome measured by the modified Rankin Scale 
(mRS). Participants also completed the Instrumental Activities of Daily Living scale (iADL), 
which assesses the ability to execute complex tasks necessary for an independent life. 
 We considered a mRS >2 or a iADL <8 a poor functional outcome. As there is no 
commonly used cut-off value for the iADL, we have chosen a cut-off value of < 8 to indicate 
poor outcome, since patients are dependent in daily life with a score < 8.  
Statistical analysis
Chi square-test was used to analyze poor functional outcome (mRS) by the presence of 
incident stroke (IS or ICH) and by time of admission (before 1980, 1990-2000 and after 
2000). Odds ratios (OR’s; 95%CI)) we calculated by means of logistic regression for the risk 
of poor outcome in IS patients only (due to small numbers with poor outcome in the 
20
other groups). Gender, age at event, duration of follow-up, NIHSS at admission, incident 
strokes and cardiovascular disease were considered confounders. We repeated this 
analysis without incident events in the model to identify baseline variables predicting 
poor functional outcome. Two-sided P values < 0.05 were considered statistical significant. 
The statistical analysis was done using SPSS 19 for Windows.
Results
Study population
1005 patients fulfilled in- and exclusion criteria of the FUTURE study, of these patients 46 
were excluded because of a history of TIA or stroke, 82 were lost to follow-up, 153 refused 
to participate and 2 did not provide any functional outcome measure resulting in 722 
patients in the current analysis. (Table 1) Compared to participants, patients lost to 
follow-up more often had an IS (76.8% vs 61.9%, less often a TIA (12.2% vs 28.8%) (p=0.001) 
and were younger at admission (38.0 vs 40.5 years, p=0.007). Compared to patients, 
patients who refused to participate had a lower NIHSS at admission (median 2 vs 3, 
p = 0.016). 
Functional outcome as assessed by the mRS
At discharge, 5 patients (2.4%) with a TIA, 135 patients (30.2%) with an IS and 46 patients 
(69.7%) with an ICH had a poor functional outcome. After a mean follow-up of 9.1 (SD 8.2) 
years, a poor functional outcome was present in 35 patients (16.8%) with a TIA, 163 patients 
(36.5%) with an IS and 33 patients (49.3%) with an ICH; of which 23 TIA patients (11.1%), 122 
IS patients (27.3%)  and 27 of the ICH patients (40.3%)  scored a mRS of 6 at follow-up. 
(Figure 1)
Functional outcome as assessed by the iADL
At follow-up 17 survivors (10.8%) with TIA, 41 (14.6%) with IS and 6 (18.2%) with ICH had a 
poor outcome on the iADL.
Contributing factors
22 TIA patients (10.6%), 64 IS patients (14.3%) and 5 ICH patients (7.5%) suffered from at 
least 1 incident stroke during follow-up (p=0.167 for overall difference). Patients with an 
incident stroke (n=91) more often had a poor functional outcome than patients without 
a recurrent stroke (mRS>2: 54.9% vs 28.7%, p< 0.001; iADL<8: 33.3% vs 11.5%, p< 0.001).
 In patients with the index event before 1990, between 1990-2000 and after 2000 the 
proportion with a poor functional outcome was 56.0%, 39.5% and 18.3% (p<0.001 for 
overall difference). Between these groups there was no difference in outcome as assessed 
by the iADL. Stratification by stroke subtype showed a similar picture. There was no cohort 
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Table 1  Baseline characteristics stratified by stroke subtype
Total TIA IS ICH
n (% of total) 722 (100) 208 (28.8) 447 (61.9) 67 (9.3)
Mean age at event, years (SD) 40.5 (7.8) 40.6 (8.0) 40.8 (7.6) 38.2 (8.5)
Men, n (%) 344 (47.6) 94 (45.2) 215 (48.1) 35 (52.2)
Median NIHSS at admission (IQR)* 3 (1-9) 0 (0-1) 5 (2-10) 14 (5-18)
Mean follow-up, years (SD) 9.1 (8.2) 8.5 (8.0) 9.7 (8.2) 6.6 (8.2)
TOAST classification, n (%)*
     Large artery 165 (25.2) 46 (21.1) 119 (26.6)
     Cardio-embolism 86 (13.1) 27 (13.0) 59 (13.2)
     Lacunar 65 (9.9) 11 (5.3) 54 (12.1)
     Other determined 96 (14.7) 23 (11.1) 73 (16.3)
     Multiple 17 (2.6) 2 (1.0) 15 (3.4)
     Undetermined 226 (34.5 99 (47.6) 127 (28.4)
* 0.6% missing.
Abbreviations: NIHSS: National Institutes of Health Stroke Scale; IQR: interquartile range; TOAST classification: 
modified Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification
Table 2  Predictors of a poor functional outcome in ischemic stroke patients
mRS> 2 iADL< 8
OR (95% CI) p-value OR (95% CI) p-value
Female sex 0.88 (0.56-1.38) 0.578 1.53 (0.72-3.26) 0.272
Age at baseline 1.05 (1.02-1.09) 0.002 1.03 (0.98-1.09) 0.249
NIHSS at admission  
(per point increase)
1.18 (1.13-1.23) <0.001 1.20 (1.12-1.29) <0.001
Incident stroke 4.24 (2.31-7.80) <0.001 7.79 (3.08-19.69) <0.001
Incident cardiovascular disease* 3.74 (1.84-7.61) <0.001 0.58 (0.14-2.40) 0.456
Duration of follow-up 0.96 (0.93-0.99) 0.007 1.01 (0.96-1.06) 0.659
*Incident cardiovascular disease: incident cardiac disease and/or peripheral artery disease
22
Figure 1   Bar diagram showing the modified rankin scale (mRS) at discharge and follow-up: 
A. All patients B. TIA patients C. IS patients D. ICH patients
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effect with respect to age at index event nor in the NIHSS at admission. Patients admitted 
before 1990 had more incident strokes than those admitted after 2000 (17.0% vs 10.1%, 
p=0.036).
Risk factors 
Risk factors for poor functional outcome (mRS >2), included the NIHSS and age at 
admission, incident stroke, sex, incident cardiovascular disease and follow-up duration. 
Significant risk factors for an iADL <8 were NIHSS at admission and incident stroke. This did 
not change after exclusion of incident events.
Discussion
We showed that even ten years after a young stroke about 1 out of 8 survivors with an IS 
or ICH (12.9%) was not able to function independently. In TIA patients this was 1 out of 15 
(6.5%) survivors. The strongest predictor of long-term functional outcome was the severity 
of the initial stroke. Also there was a clear relationship between the occurrence of one or 
more incident strokes and poor long-term functional outcome, stressing the importance 
of optimal preventive strategies in this population.
 Strengths of our study were the prospective and single center design. Furthermore, 
our study has one of the longest follow-up durations reported and one of the largest 
cohorts in the field of young stroke. 
 A limitation is the small number of ICH patients included, albeit the largest “young 
ICH” sample with long-term follow-up so far. Furthermore, length of stay affects mRS at 
discharge and as a consequence a single group of patients with one and the same mRS at 
discharge, might actually be composed out of several groups (with longer and shorter 
lengths of stay), each with their potential of recovery and thereby functional status at 
follow up.
 The period of recruitment of this cohort included 30 years during which major 
improvements in stroke care and secondary prevention took place. This was reflected by 
the on average better outcome in patients who had been admitted more recently and 
the higher proportion of incident stroke in the before 1990 cohort compared with the 
cohorts thereafter, although obviously those with a long follow up have been exposed 
much longer, have become older and are likely to have experienced more comorbidity 
that all may have accounted for a poorer functional outcome.  
 In previous studies, poor functional outcome in IS patients ranged from 3% to 7% 
after mean follow-up durations between 4 and 12 years.2-4 These studies showed a slightly 
better outcome than ours, possibly explained by the inclusion of older patients (up to 50 
instead of 45 years of age) or a longer follow-up duration in our study. Furthermore, in 
these previous studies functional outcome was measured only by either the mRS or the 
24
Glasgow Outcome Scale, which are rather global scales for outcome. We intentionally 
used two different methods to determine functional outcome. In our population we 
found that almost 15% of all survivors experienced some problems in iADL tasks, even 
almost 10 years after stroke. 
 Prognosis after young ischemic and hemorrhagic stroke is rather poor; one out of 
eight young stroke survivors is not able to live an independent life, even after almost 10 
years after stroke. 
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Abstract
Background and purpose: Due to their young age young stroke survivors have to cope 
with a dramatic impact on their life for the decades to come. We investigated the 
sex-specific very long-term functional outcome after transient ischemic attack (TIA) and 
ischemic stroke (IS) in adults aged 18 through 50 years.
Methods: This study is part of a cohort study among 619 first-ever young ischemic stroke 
patients, admitted to our department between January 1, 1980 and November 1, 2010. 
Functional outcome was assessed during follow-up in 2009-2011 and in 2014-2015 with 
the modified Rankin Scale (mRS) and instrumental Activities of Daily Living scale (iADL). 
Risk factors for a poor functional outcome (mRS>2 and iADL<8) were calculated by logistic 
regression analysis.
Results: After a mean follow-up of 13.9 (SD8.2) years, 24.5% of TIA patients and 44.7% of IS 
patients had a poor functional outcome (mRS>2). When assessing the survivors, 15.2% of 
TIA patients and 22.9% of IS patients had a poor outcome as assessed by iADL. The 
strongest baseline predictors of poor outcome were female sex (OR 2.7, 95% CI 1.5-5.0) and 
baseline NIHSS (OR 1.1, 95% CI 1.1-1.2 per point increase).
Conclusions: Fourteen years after an ischemic cerebrovascular event in young adults, 
one out of five IS survivors and one out of ten TIA survivors is still dependent in daily life, 
with a two to threefold higher risk of a poor outcome in women. This includes a period of 
life, during which important decisions regarding work and family life have to be made.
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Introduction
The proportion of strokes occurring in young adults has increased over the past decade 
up to almost 20% of all strokes.4 At a young age stroke has a major impact on psychological 
and social functioning, since in general at this age people are active participants in the 
community. Consequently, uncertainty about their long-term functional outcome may 
affect patients’ choices in personal and occupational issues.14
 Recently, we have shown that the functional prognosis of young stroke patients is 
worse than previously assumed. On average 10 years after an ischemic stroke (IS), 1 out of 
8 survivors is dependent in daily life with an even higher proportion dependent with 
increasing follow-up duration.15 Also, we found that a substantial proportion of the 
patients deteriorated from their modified Rankin Scale (mRS) immediately after stroke 
compared with their mRS at follow-up.
 As patients, their caregivers and health professionals rank prognosis after stroke 
among their top 10 priorities with regards to life after stroke,10 we wanted to investigate 
whether post-stroke recovery is still possible, even after 10 years of follow-up or longer. As 
women are overrepresented among the younger (< 30 years) stroke survivors16 and 
prognosis among female stroke victims in general is known to be poorer17 we explicitly 
wanted to investigate the sex-specific very long-term prognosis. In addition, we aimed to 
evaluate which determinants predicted the risk of a poor very long-term functional 
outcome and the changes over time therein. 
Methods
This study is part of the “Follow-Up of Transient ischemic attack and stroke patients and 
Unelucidated Risk factor Evaluation”-study (FUTURE study). The design of the FUTURE 
study has been described previously.18 In short, the FUTURE study is a prospective cohort 
study that aims to investigate causes and consequences of young stroke. The Medical 
Review Ethics Committee region Arnhem-Nijmegen approved the study and we received 
consent forms from all participants in the study.
Patients
The FUTURE study comprised all consecutive patients with a TIA, IS or intracerebral 
hemorrhage (ICH), between ages 18 – 50 years, admitted to the Radboud University 
Medical Center Nijmegen, the Netherlands, from January 1, 1980 and November 1, 2010. 
Only surviving patients with first-ever TIA or IS were included in the present study because 
of the different pathophysiology underlying ICH. To minimize bias due to changing 
diagnostic techniques, the World Health Organization definition for TIA and stroke was 
used.1, 2 TIA was defined as a rapidly evolving focal neurological deficit, without positive 
30
phenomena such as twitches, jerks or myoclonus, with no other than a vascular cause 
lasting less than 24 hours. Stroke was defined as focal neurological deficits persisting for more 
than 24 hours. On basis of radiological findings, stroke was subdivided into ICH and IS. 
 Exclusion criteria were cerebral venous sinus thrombosis and retinal infarction. For the 
present study we also excluded patients from whom we could not obtain any of the 
functional outcome measures at the second follow-up moment in 2014-2015.
 Patients were identified through a prospective registry of all consecutive young 
stroke patients that has been maintained at the department since the 1970’ies19 with a 
standardized collection of baseline and clinical characteristics (including demographics, 
stroke subtype and vascular risk factors). Cardiovascular risk factors at baseline were 
defined either as a history of a risk factor (mentioned in medical history or the use of 
medication) or as a risk factor detected during admission or analysis of the stroke as 
follows: diabetes mellitus as a random blood glucose level greater than 11.1 mmol/L or 2 
consecutive fasting venous plasma glucose levels of 7.0 mmol/L or greater;20 hypertension 
as systolic blood pressure 135 mm Hg or greater and/or diastolic blood pressure 85 mm 
Hg or greater, measured after the first week of the index event; and atrial fibrillation when 
identified on either an electrocardiogram or during continuous electrocardiographic 
recording. Smoking was defined as smoking at least 1 cigarette per day in the year prior to 
the event. 
 Furthermore all patients underwent a neurological examination and brain imaging at 
the time of their index event.18 The assessment of both the etiology (modified Trial of ORG 
10172 in Acute Stroke Treatment (TOAST) classification)21 and severity (National Institutes 
of Health Stroke Scale (NIHSS)22) at admission was done for all cases retrospectively by a 
validated approach,23, 24 as these scales did not exist at the time when a substantial 
proportion of our patients experienced their qualifying event. 
Follow-up
Information on the vital status was available either from the hospital or via the municipality 
registry.9 Patients alive were invited for follow-up assessment consisting of questionnaires 
between November 1, 2009 and January 1, 2012. Subsequently, between August 1, 2014 
and January 15, 2015 TIA and IS patients alive were approached by telephone to assess 
their functional outcome25 as well as incident events using a standardized interview. 
Functional outcome 
Our primary outcome measure was the functional outcome of patients at the second 
follow-up moment (2014-2015) and the change in functional outcome from the first 
(2009-2012) to the second follow-up wave. Functional outcome was measured by the 
modified Rankin Scale (mRS).26 This scale ranges from perfect health without symptoms 
(0) to death (6). The ability to carry out more complex activities was assessed with the 
instrumental Activities of Daily Living scale (iADL).27, 28 This scale assesses a person’s ability 
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to perform tasks such as using a telephone, doing laundry and handling finances, and 
leads to a summary score ranging from 0-8 (low to high function).
 A poor functional outcome was defined as either a mRS >2 or poor performance on 
the iADL as a score <8, corresponding with dependency in daily life. Whereas we used a 
common cut-off value for poor outcome on the mRS (>2),29-31 there is no such commonly 
used cut-off value for the iADL. However, loss of independence on any iADL task is usually 
regarded as an impaired iADL.15, 32 Therefore we have chosen a cut-off value of  <8 to 
indicate poor functional outcome. A deterioration in functional outcome was regarded as 
a change from a good functional outcome (mRS ≤2/ iADL = 8) to a poor functional 
outcome (mRS >2/ iADL <8).
Incident cardiovascular disease
The occurrence of an incident stroke (IS or ICH) or other cardiovascular disease (cardiac 
disease, including myocardial infarction, coronary artery bypass grafting and percutaneous 
coronary intervention for coronary artery disease, and peripheral artery disease) was 
assessed with a standardized, structured questionnaire. Whenever an event was 
suspected, information was retrieved from the treating physicians and subsequently 
verified by specialists from the appropriate field, who were blinded to both the index 
event and functional outcome. 
Statistical analysis
Differences in baseline characteristics between TIA and IS patients were analyzed with 
chi-square tests for categorical variables, ANOVA or Kruskal-Wallis tests when appropriate. 
Descriptive statistics were used to describe the long-term functional outcome (mRS/iADL) 
and the change in functional outcome between the first and second follow-up moment. 
Characteristics of patients with a poor functional outcome and those who deteriorated 
were analysed with chi-square tests. We repeated this analysis stratified by time of 
admission (before 1980, 1990-2000 and after 2000), by age at baseline (<35, 35-45 and >45 
years) and sex.
 By means of logistic regression, we calculated odds ratios (OR’s) with their corresponding 
95% confidence intervals for the risk of poor outcome as assessed by the mRS and the 
iADL. Covariates in the model were type of index event (IS or TIA), sex, age at event, NIHSS 
at admission, duration of follow-up, incident strokes and incident cardiovascular disease. 
Two-sided P-values of less than 0.05 were considered to indicate statistical significance. 
The statistical analysis was done using SPSS 20 for Windows.
32
Results
For the present study 619 patients with a first-ever TIA and IS were included in the analysis 
(Figure 1). Compared with participants, patients who were lost to follow-up more often 
had an IS (82.6% vs 68.3%, p=0.005), were slightly younger (38.6 (SD 8.3) vs 40.9 (SD 7.7) 
years, p=0.010) and less often suffered from hypertension (18.5% vs 36.0% patients, 
p=0.001) and diabetes mellitus (2.2% vs 8.4%, p=0.035). Compared with participants, 
patients who refused to participate were slightly younger (39.3 (SD 8.0) vs 40.9 (SD 7.7) 
years, p=0.017) and less often suffered from hypertension (26.1% vs 36.0%, p=0.019); 
no differences in any of the other baseline characteristics were found. The baseline 
 characteristics are presented in table 1. During a mean follow-up of 13.9 (SD 8.5) years 
90 patients (14.5%) suffered from an incident stroke, of which 84 patients (93.3%) had an IS 
and 6 (6.7%) an ICH. 
Figure 1   Flow chart of the study population
Follow-up study population 
n=776 
Baseline study population 
n=1005 
Lost to follow-up:  
- First follow-up wave 2009-2012: n = 84 
- Second follow-up wave 2014-2015: n = 19  
Exclusion due to history of TIA or stroke: n = 44
 
 
Refused to participate in FUTURE study:  
- First follow-up wave 2009-2012: n = 139 
- Second follow-up wave 2014-2015: n= 18 
 
619 patients  
 
ICH-patients: n = 82 
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Functional outcome 
After a mean follow-up of 13.9 (SD 8.5) years, a poor functional outcome on the mRS was 
present in 48 patients (24.5%) with a TIA and 189 patients (44.7%) with an IS, of whom 32 
TIA patients and 135 IS patients had died at follow-up (mRS=6). There was a significant 
difference in the proportion of patients with poor outcome between TIA patients and IS 
patients (p<0.001). 118 Men (39.9%) and 119 (36.8%) women had a poor functional outcome 
on the mRS (p=0.490), although women were significantly younger (39.7 vs 42.0 years, 
p=0.001) and had a lower NIHSS (median 2 vs 4, p=0.003) than men.
 At follow-up 25 patients (15.2%) with TIA and 66 patients (22.9%) with IS had a poor 
functional outcome on the iADL. This did not significantly differ between TIA and IS 
patients (p=0.067). 34 Men (16.9%) and 57 (22.7%) women had a poor functional outcome 
on the iADL (p=0.159).
Table 1  Baseline characteristics stratified by stroke subtype
Total TIA IS p-value
n (% of total) 619 (100) 196 (31.7) 423 (68.3)
Mean age at event, years (SD) 40.9 (7.7) 40.7 (8.0) 40.9 (7.6) 0.903
Men, n (%) 296 (47.8) 88 (44.9) 208 (49.2) 0.366
Median NIHSS at admission (IQR)a 3 (1-8) 0 (0-1) 5 (2-10) <0.001
Mean follow-up, years (SD) 13.9 (8.5) 12.3 (8.3) 14.7 (8.5) 0.002
Cardiovascular risk factors, n (%)
     Hypertension 223 (36.0) 68 (34.7) 155 (36.6) 0.704
     Diabetes mellitus 52 (8.4) 12 (6.1) 40 (6.5) 1 (2.5)
     Atrial fibrillation 12 (1.9) 3 (1.5) 9 (2.1) n/a
     Recent smokinga 306 (52.0) 78 (40.6) 228 (57.4) <0.001
TOAST classification, n (%)
     Large artery 464 (75.0) 43 (21.9) 112 (26.5) 0.266
     Cardio-embolism 155 (25.0) 26 (13.3) 55 (13.0) 1.000
     Lacunar 62 (10.0) 11 (5.6) 51 (12.1) 0.019
     Other determined 89 (14.4) 21 (10.7) 68 (16.1) 0.100
     Multiple 17 (2.7) 2 (1.0) 15 (3.5) 0.127
     Undetermined 215 (34.7) 93 (47.4) 122 (28.8) <0.001
aIn 0.5% of the patients NIHSS at admission and in 4.8% smoking status was missing.
Abbreviations: NIHSS: National Institutes of Health Stroke Scale;IQR: interquartile range;TOAST classification: 
modified Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification
34
Transition in functional outcome
49 Patients (11.5%) deteriorated from good to a poor functional outcome between the 
first (2009-2011) and second (2014-2015) follow-up, of whom 18 had died (Figure 2). 
In contrast, only 5 patients (1.3%) improved from poor to good functional outcome. 
Patients with deterioration did not significantly differ in age at index event nor in the 
decade in which their index event took place compared to patients without deterioration. 
12 Of these patients (24.5%) had suffered from a recurrent stroke compared to 78 patients 
(13.7%) of the patients without deterioration (p=0.065). The number of these patients who 
suffered from another incident vascular event was similar to patients without deterioration 
(16.3% vs 14.4%, p =0.874). Women more often deteriorated in functional outcome 
(as measured with the mRS) than men (10.5% vs 5.1%, p=0.018).
 36 Patients (10.3%) who had an iADL of 8 at the first follow-up moment (on average 
five years ago) now declined to an iADL <8. Seven patients (15.6%) with an iADL <8 at the 
first follow-up moment improved to a good functional outcome on the iADL. Women 
more often deteriorated with regards to their functional outcome (iADL) (11.2% in women 
vs 6.7% in men, p=0.171), but this was not significant. No significant differences in the 
proportion of patients who had suffered from an incident event was seen between 
patients with and without deterioration. 
Risk factors
Table 2 shows the risk factors for poor functional outcome in young TIA and IS patients. 
Multiple regression analysis revealed that a poor functional outcome on the mRS was 
predicted by female sex (OR 2.7; 95%CI 1.5-5.0), higher age at stroke onset (OR 1.0; 95% CI 
1.0-1.1 per year), higher NIHSS at admission (OR 1.2; 95%CI 1.1-1.2 per point increase) and 
the occurrence of an incident stroke (OR 5.7; 95%CI 2.9-11.2). A poor functional outcome 
on the iADL was predicted by female sex (OR 2.0; 95%CI 1.2-3.4), a higher NIHSS at 
admission (OR 1.2; 95% CI 1.1-1.3 per point increase) and the occurrence of an incident 
stroke (OR 5.0; 95%CI 2.6-9.6). 
 The proportion of patients with a poor functional outcome was 61.6%, 47.0% and 
23.7%, depending on the decade of their index event (before 1990, between 1990-2000 
Figure 2   Change of modified Rankin scale scores after stroke in young adults (n=619)
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and after 2000; p<0.001 for overall difference). In patients aged <30 years, 30-40 years and 
>45 years at the time of their index event the proportion with a poor functional outcome 
was 27.3%, 33.1% and 42.7% (p=0.015 for overall difference). Between these groups there 
were no differences in outcome as assessed by the iADL. 
Discussion
We showed that on average 14 years after an ischemic stroke in a young adult almost one 
out of five long-term survivors (18.8%) was not able to function independently based on 
the mRS. In surviving TIA patients this is one out of ten patients (9.8%). About one out of 8 
(11.5%) of the surviving patients with a good functional outcome during the first follow up 
(on average 10 years after the qualifying event) lost independency in daily life or died 
during the second follow up (on average 14 years after the event). In contrast, almost one 
out of six (15.6%) of the very long time survivors improved to a good functional outcome 
on the iADL in comparison to the first follow-up moment. 
 The strength of our study was the long follow-up duration, which is the longest 
follow-up reported in the field of young stroke, and the ability to detect change in 
prognosis due to repeated follow-up assessments which enabled us to give more accurate 
information about the very long-term prognosis after stroke at young age. In addition, our 
study had a prospective and single center design, which allowed us to collect information 
systematically and to uniformly verify both the index event as well as the outcome, 
thereby reducing the risk of information bias, although a single center design could limit 
Table 2  Predictors of a poor functional outcome in young TIA and IS patients
mRS > 2 iADL < 8 
OR (95% CI) p-value OR (95% CI) p-value
Ischemic stroke* 0.8 (0.4-1.6) 0.537 0.6 (0.3-1.1) 0.099
Female sex 2.7 (1.5-5.0) 0.001 2.0 (1.2-3.4) 0.013
Age at baseline 1.0 (1.0-1.1) 0.026 1.0 (1.0-1.1) 0.118
NIHSS at admission (per point increase) 1.2 (1.1-1.2) <0.001 1.2 (1.1-1.3) <0.001
Incident stroke 5.7 (2.9-11.2) <0.001 5.0 (2.6-9.6) <0.001
Incident cardiovascular disease** 1.1 (0.5-2.4) 0.863 1.0 (0.5-2.2) 0.984
Duration of follow-up (years) 1.0 (1.0-1.1) 0.212 1.0 (1.0-1.0) 0.432
*TIA patients serve as the reference group
** Incident cardiovascular disease: incident cardiac disease and/or peripheral artery disease
36
the generalizability slightly in comparison to multi-center designs. However, the risk of this 
is low, therefore we consider it likely that our results can be generalized to most of the 
young stroke population, especially those who are already months to years past their 
initial stroke.
 However, there are also some limitations. Selection bias may have occurred due 
to selective loss to follow-up. Both patients lost to follow-up and refusers suffered 
substantially more often from hypertension at baseline. Therefore non-participants 
possibly were at a higher risk of incident events and thus an increased risk of a poor 
functional outcome. Our findings therefore most likely represent an underestimation of 
the true long-term functional prognosis after stroke in young adults. In addition, possibly 
not all deficits reported in either of the questionnaires were caused by direct effects of the 
index stroke, since comorbidity can also lead to the inability to function independently. 
However, irrespective of the disease underlying the loss of independence, it is remarkable 
to note the large proportion of still young patients that require help in daily life, on average 
14 years after stroke. Finally, during the long inclusion window there have been considerable 
changes in stroke care, possible resulting in changes in prognosis after stroke at young 
age as well. We did show a worse prognosis in patients who were admitted with their 
index event longer ago, however, it cannot be concluded that this is (entirely) due to these 
changes in care, since these patients also have been at risk to develop recurrent events 
and comorbidities for a longer period of time.
 In previous studies, poor functional outcome in young IS patients ranged from 3% 
to 7% after mean follow-up duration between 4 and 12 year,29, 33, 34 better than in our 
study. This could partly be explained by inclusion of older patients (up to 50 instead of 45 
years of age) in our study. Furthermore, in these previous studies functional outcome was 
measured only by either the mRS or the Glasgow Outcome Scale (GOS), which are 
commonly used, but are rather global scales for outcome. We intentionally used an 
additional, complimentary method to determine functional outcome. The iADL (only for 
survivors) takes into account the ability to perform very specific tasks relevant for living 
independently, whereas the mRS is a functional outcome measure that is very much 
dependent on motor performance. These tasks not only rely upon physical health, but 
also require cognitive function at some level.35 Consequently the use of these cut-offs of 
these different scales will result in different groups. 
 ‘Statistics Netherlands’ published data on disabilities in the general Dutch 
population.36 Unfortunately the iADL scale is only reported in patients over 55 years of age. 
However, they do provide information on disability on an OESO-scale, which gives quite a 
similar impression of disability as the iADL scale. Items on this OESO-scale are walking 
unaided by another person for 400 meters, taking part in a conversation, reading a paper, 
carrying groceries, picking up an item from the floor. They report that 14.0% of people 
between 50 and 55 years (the average age of our patients at follow-up) experience 
problems on at least one of the items of this scale (in our study 15.2% of TIA patients and 
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22.9% of IS patients experienced problems in iADL). Younger people experience this in 
≤7.1% of the cases. Although this is not a case controlled study, especially IS patients have 
a much higher (50%) risk of disability than individuals from the general population. 
 Finally, we attempted to identify risk factors for long-term poor functional outcome. 
Interestingly, women had a two to threefold higher risk of a poor outcome than men. This 
sex-difference in long-term functional outcome after stroke has previously been described 
in the elderly stroke population.14, 17, 37 It is assumed that the sex-differences could be 
(partially) explained by a more advanced age, poorer prestroke functionality, more 
comorbidities, a tendency to suffer from more severe strokes and less social support in 
women in comparison to male stroke patients.14, 17, 37  In our study we observed the 
increased risk of poor outcome in women despite adjusting for stroke severity, age at 
initial stroke and the presence of incident events, implying that other underlying 
mechanisms are involved. There is ongoing research to identify biological mechanisms 
clarifying the sex-differences in stroke patients, which mainly focuses on the role of sex 
steroid hormones.37 
 Providing patients and relatives with information is an important aspect of clinical 
practice. Therefore, it is important to realise that female sex and the initial stroke severity 
are the strongest baseline determinants of poor long-term functional outcome. In 
addition, higher age at the time of the index event is associated with an increased risk of 
poor functional outcome. These parameters are objective, easy to assess and readily 
available in the acute phase. Patients and their caregivers should be informed about the 
long-term prognosis to give them the opportunity to make educated choices about 
career moves and family planning. 
 In conclusion, the very long-term functional prognosis after young stroke is worse 
than previously assumed. Up to one out of five young ischemic stroke survivors is not able 
to live independently almost 14 years after stroke. In addition, very long-term poor 
functional prognosis was seen in almost one out of ten young TIA survivors. This is 
important information for patients, their caregivers and for health professionals when 
counselling their patients on the course of the disease. In addition, the continuous decline 
in functional outcome long after the initial stroke seen in our population suggests that 
long-term care and follow-up is needed for young stroke patients. Further research is 
needed to clarify the etiology and to identify explanations of the observed sex differences 
of the ongoing decline in young stroke patients and to assess whether additional 
preventive strategies could decrease the proportion of patients with late deterioration.  
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Abstract
Background and purpose: Long-term prognosis in terms of quality of life (QoL) in young 
stroke patients is of importance because they usually have a long life expectancy and 
extensive daily life demands. We aimed to determine which medical and psychological 
factors influence the QoL in young stroke patients (<50 years), after long-term follow-up.  
Methods: Young ischemic stroke patients admitted to the St. Elisabeth hospital and the 
TweeSteden hospital, Tilburg, the Netherlands, between 2000-2010 were included. 170 
patients and 61 controls filled out the following questionnaires: (1) the Hospital Anxiety 
and Depression Scale (HADS), (2) the Fatigue Assessment Scale (FAS) and (3) the shortened 
World Health Organization Quality of Life scale (WHOQOL-BREF26). Using linear multiple 
regression analysis we assessed the factors influencing QoL. 
Results:  QoL did not differ significantly between patients (median mRS at follow-up 0) 
and controls after a mean follow-up of 4.5 (SD 2.8) years. The presence of excessive fatigue 
was associated with lower scores on all domains of the QoL p≤0.003), but not for general 
health domain (p=0.010). Similarly depression was associated with worse QoL on the 
physical (p=0.004) and psychological (p=0.001) domains and anxiety with lower scores on 
the psychological (p<0.001) QoL domain. No relationship was found between stroke- 
specific factors and QoL.
Conclusions: Fatigue and to a lesser extent depression and anxiety affect the QoL in 
young adults after ischemic stroke of mild severity. Therefore young stroke patients should 
be informed about, screened and, if possible, treated for fatigue, depression and anxiety. 
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Introduction
Up to 12% of all strokes occur in adults under the age of 45 years.29 Short-term prognosis 
is considered more favourable than in older patients, because of lower mortality and 
better functional outcome.5 Recently more information has become available about the 
long-term mortality and recurrence rate.8, 9 Young stroke patients are more likely to be 
divorced, unemployed and more often develop depression, anxiety or fatigue.31, 38-40 This 
might be the result of the more severe impact of stroke on psychological and social 
functioning in this age category. 
 However, only limited information is available about long-term quality of life (QoL) 
after young stroke and which are the most important factors influencing QoL in this 
specific population. Most likely, QoL is not only influenced by motor disabilities but also by 
coping style, mental capacities and adjusting life purposes in relation to health changes. 
Stroke patients often suffer from fatigue and depression.31, 41, 42 One previous study 
demonstrated the major role of these factors in QoL in young patients.31 
 In this study we evaluated the factors affecting the QoL after ischemic stroke in 
young adults. We hypothesised that QoL after stroke is affected both by stroke specific 
factors, like stroke severity, and by psychological factors. We attempted to define which of 
these factors influence QoL most. 
Methods
Patient selection
All consecutive patients who presented with an ischemic stroke in the St. Elisabeth 
Hospital and the TweeSteden Hospital, Tilburg, the Netherlands, between January 1st, 
2000 and December 31st 2010 were included if they met the following inclusion criteria: (1) 
clinical diagnosis of ischemic stroke (focal neurological deficit persisting for more than 
24 hours of presumably vascular origin) retrospectively confirmed by a stroke-neurologist 
with or without radiological confirmation (CT or MRI) (2) age between 18 and 49 years at 
the time of the index event. Patients with a history of previous ischemic stroke were 
excluded. We recruited appropriate cases retrospectively by searching in the Electronic 
Medical File and existing stroke-databases. Follow-up was done between April 2011 and 
June 2011. All eligible patients were approached with an information letter. When 
necessary, we contacted the general practitioner to verify their vital status. When patients 
did not respond to the first letter and a second reminder, they were considered to be 
non-participants. 
 The Medical Research Ethics Committee of the St. Elisabeth hospital approved the 
study protocol.
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Baseline data ascertainment
All baseline data were retrospectively derived from patient files. We analyzed the following 
demographical and clinical characteristics: age of onset, sex, follow-up period, type of 
infarction (according to the Oxford Community Stroke Project criteria (OCSP)43: total 
anterior circulation infarction (TACI), partial anterior circulation infarction (PACI), lacunar 
infarction (LACI) and posterior circulation infarction (POCI)), NIHSS score (National Institute 
of Health Stroke Scale, determined retrospectively based on clinical signs at presentation)24, 
vital status (and if deceased: we identified the cause of death) and stroke recurrence. 
Information on stroke recurrence was derived from patient files in both hospitals.
Follow-up assessment
Follow up was done by the following standardized structured questionnaires that were 
sent out by mail:
(1)  the shortened World Health Organization Quality of Life scale (WHOQOL-BREF 26). 
In the WHOQOL-BREF 26, five QoL domains are evaluated on a scale of 4 to 20: 
physical health, psychological functioning, social relationships, environment and 
an additional domain for general QoL (Table 1).44
(2)  the Fatigue Assessment Scale (FAS). The FAS is a 10 items questionnaire focussing 
on physical and mental fatigue. A score of  > 22 is considered indicative of excessive 
fatigue.45, 46
(3)  the Hospital Anxiety and Depression Scale (HADS). The HADS is divided in two 
components, one for depressive symptoms and one for anxiety symptoms. A score 
> 7 on one of these components is suggestive of a depression or anxiety disorder 
respectively.47, 48
Table 1  QoL domains as assessed with the WHOQOL-BREF 26
Domain Components
Physical health Activities of daily living, dependence on medication and medicinal aids, 
energy and fatigue, mobility, pain and discomfort, sleep and rest, work 
capacity
Psychological Bodily image and appearance, negative and positive feelings, self-esteem, 
spirituality, cognition
Social relationships Personal relationships, social support, sexual activity
Environment Financial resources, freedom, health and social care, home environment, 
opportunities for acquiring new information, participation in recreation, 
physical environment, transport
General health Self perception of health and quality of life
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Patients were contacted by phone to assess the modified Rankin score (mRS)26 and their 
current employment status.  
Controls
Controls were recruited from the COMPlaints After Stroke (COMPAS) study,17 a simultaneously 
running study in both hospitals. This study investigates post-stroke subjective cognitive 
complaints. The control group consists of a sample from the non-stroke general population 
and is recruited among the relatives and the social networks of participants in the COMPAS 
study. People with pre-existent cognitive decline, a recent history of severe psychopathology 
and severe physical comorbidity were excluded. These people had filled out the same 
questionnaires as our patients. From this control group we selected the controls under the 
age of 57 years at the moment of testing to obtain an age-matched control group. 
Statistics
We used Chi square tests and Mann-Whitney U tests when appropriate to compare 
baseline characteristics between patients and controls and between participants and 
non-participants. Using MANOVA we compared the different domains of QoL between 
patients and controls, adjusting for age at follow-up, sex, anxiety and depression score 
(HADS) and fatigue score (FAS). Finally by multiple regression analysis we determined 
which factors influenced QoL most. The following independent variables were chosen: 
age at admission, sex, duration of follow-up, NIHSS at admission and the following 
follow-up variables: mRS, FAS-score >22, anxiety score >7 (implicating an anxiety disorder), 
depression score >7 (implying depression) and employment status. As both the MANOVA 
and the multiple regression analysis were done for five distinct cognitive domains, the 
threshold for significance in these analyses was set to a Bonferroni-adjusted p-value of 
0.01. We excluded collinearity by checking for Pearson correlation coefficients. The highest 
correlations are reported in the results. We performed all statistical analysis using SPSS 19 
for Windows.
Results
Baseline characteristics
In total 340 patients met the inclusion criteria of whom 170 patients participated in the 
present study (Figure 1). Mean age at follow-up was 46.3 (SD 7.1) years. Mean duration of 
follow-up was 4.9 (SD 2.7, range 1.0-11.0) years. Median mRS at follow-up was 0 (range 0-5), 
89.4% of the patients had a mRS of ≤ 2 (no or slight disability).
44
 Participants did not significantly differ from non-participants with respect to age or 
side of ischemia. However, more males participated (44.1% vs. 26.1%; p=0.001) and few 
participants had a severe stroke (NIHSS > 12; 7.6% vs. 19.4%, p=0.002). There were no 
significant differences in cardiovascular risk factors except for current smoking (55.3% vs. 
23.2%; p=<0.001). 
 We included 61 controls. Age and sex were not significantly different between patients 
and controls. Patients scored significantly worse on depression (HADS) and fatigue (FAS) 
(p<0.001) and had lower employment rates (p<0.001) than controls. (Table 2)
Quality of life
With respect to QoL (WHOQOL-BREF) none of the domains differed significantly between 
patients and controls, although a trend was seen for lower scores on the ‘environment’ 
domain in patients (15.1 (SD 2.7) vs 17.5 (SD 2.1), p = 0.010). (Table 3) This domain focuses on 
aspects like safety, financial status, transport and recreation. (Table 1)
Figure 1   Flowchart of patient inclusion
First ever young ischemic stroke patients 
between 2000-2010  
n = 340 
 
Patients approached by letter 
n = 293 
Deceased: n = 39 
Unknown address: n = 8 
 
Study population 
n = 170 
No response: n = 82 
 
Did not want to participate: n = 26 
 
Exclusion due to follow-up < 1 year: n = 15 
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Influence of stroke specific factors
Using multiple regression analysis we could not detect a significant influence of any of the 
stroke specific factors on the QoL. (Table 4) 
Influence of psychological factors 
The presence of excessive fatigue was associated with lower scores on all domains of 
the QoL investigated (p≤0.003), apart for the general health domain (p=0.010). (Table 4) 
Figure 2 shows this in a univariate model. Similarly the presence of depression was 
associated with worse QoL on the physical (p=0.004) and psychological (p=0.001) domains. 
The presence of an anxiety disorder was associated with lower scores on the psychological 
QoL domain (p<0.001). (Table 4)
 The presence of excessive fatigue was also correlated with the presence of a depression 
(r=0.613, p <0.001) and an anxiety disorder (r=0.402, p<0.001). The presence of a depression 
and an anxiety disorder modestly correlated with each other (r=0.587, p<0.001).
Table 2  Baseline characteristics: Comparison between patients and controls 
Patients  (n=170) Controls (n=61) p-value
Mean age at admission in years (SD) 41.4 (7.0)
Mean age at follow-up in years (SD) 46.3 (7.1) 48.0 (6.6) 0.061
Mean follow-up in years (SD, range) 4.9 (2.7, 1-11)
Men, n (%) 75 (44.1) 20 (32.8) 0.164
NIHSS at admission, median (quartiles) 3 (1-5)
NIHSS at admission  ≥ 12, n (%) 13 (7.6)
Type of ischemia, n (%)
     TACI 9 (5.3)
     PACI 56 (32.9)
     LACI 52 (30.6)
     POCI 53 (31.2)
Mean HADS anxiety score (SD)* 5.9 (4.6) 4.4 (3.6) 0.063
     Anxiety score > 7, n (%) 53 (31.9) 8 (17.8) 0.095
Mean HADS depression score (SD)** 6.4 (5.1) 2.7 (3.5) <0.001
     Depression score >7, n (%) 61 (37.2) 3 (6.7) <0.001
Mean FAS score (SD)*** 25.5 (8.8) 18.3 (5.2) <0.001
     FAS score > 22, n (%) 96 (57.8) 7 (15.9) <0.001
Current employment, n (%) 108 (63.5) 58 (95.1) <0.001
* 20 missing data ** 22 missing data ***21 missing data
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Table 3  Scores on the WHOQOL-BREF 26: Comparison between patients and controls 
Domains Patients* Controls* p-value**
Physical health 14.3 17.1 0.021
Psychological 13.9 15.6 0.960
Social relationships 14.7 15.8 0.270
Environment 15.1 17.5 0.010
General health 14.1 17.1 0.033
*Lower scores indicating lower quality of life on a scale of 4-20 for each domain.
** The threshold for significance in these analyses was set to a p-value of 0.010
Table 4   β-coefficients (multivariate regression) for prediction of quality of life on  
5 separate domains in young stroke patients  
Domains QoL
Physical Psychological Social Environment General
Stroke specific factors
    Age at qualifying event -.048 -,061 -.076 .023 .031
    Sex -.016 -.011 -.167 -.028 -.109
    Duration of follow-up -.043 -.080 -.165 -.096 -.013
    NIHSS .022 -.157 -.030 -.077 .129
    mRS -.035 .078 .007 .109 -.108
Psychological factors
    FAS > 22 -.324** -.263* -.415** -.403** -.273
    Anxiety score >7 -.171 -.297** .042 -.143 -.215
    Depression score >7 -.281* -.337* -.075 -.162 -.227
Social factors
    Employment .272* .115 .214 .249 .076
The threshold for significance in these analyses was set to a p-value of 0.010.
* p-value < 0.010 ** p-value < 0.001
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Influence of employment
Unemployment at follow-up was associated with lower scores on the physical QoL 
domain (p=0.001), but was not associated with the other QoL domains. 
 Unemployment was correlated to the presence of a depression (r=0.407, p<0.001), 
an anxiety disorder (r=0.274, p<0.001), fatigue (r=0.405, p<0.001) and a higher mRS 
(r=0.574, p<0.001).
Figure 2   Flowchart of patient inclusion
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Discussion
Even though a trend was seen towards lower scores than controls on the ‘environment’ 
domain of QoL, there were no significant differences in QoL between young stroke 
patients and controls after long term follow-up (mean 4.9 years). Multiple regression 
analysis showed that especially fatigue and to a lesser extent depression, anxiety and 
unemployment negatively influenced QoL. Depression and fatigue were both highly 
prevalent years after stroke at young age in comparison to controls. Interestingly, variables 
related to stroke severity like NIHSS at admission and mRS at follow-up were not related 
to QoL. 
 The strengths of our study are the large number of young stroke patients included 
and the long mean follow-up period. Furthermore, both hospitals involved in this study 
were collaborating and together provide stroke care for a wide geographical area in the 
Netherlands. It is highly unlikely that young stroke patients in this area would not have 
been referred to one of these two hospitals. However, only few patients with moderate to 
severe disabilities were included (mRS >2). Therefore our results cannot be generalized to 
all young stroke patients, but are representative for patients who suffered a stroke of mild 
severity.
 A limitation of our study is that baseline data were retrospectively derived from 
patient records. To minimize misclassification all stroke diagnoses were revised by a 
stroke-neurologist and initial imaging was reviewed, excluding patients false-positively 
diagnosed with strokes. Selection bias could have occurred because symptoms of 
depression and fatigue may have hindered the completion of the questionnaire, possibly 
leading to an overestimation of the QoL in young stroke patients. This, in combination 
with the relatively small number of controls, could explain why we did not detect a 
significant difference in QoL between patients and controls. 
 Although our study did not show a consistently diminished QoL years after stroke in 
young patients, we did detect a very strong and consistent relation of fatigue with QoL 
and to a lesser extent with depression, anxiety and unemployment, whereas in contrast 
to our hypothesis, no relationship between QoL and motor-related variables (NIHSS, mRS) 
was seen. Also unexpected, we found a very strong relationship between excessive 
fatigue and QoL. In the general stroke population fatigue is reported in about 40% of the 
patients.49, 50 Even though fatigue is often regarded as a mainly psychological factor, 
fatigue is probably caused by multiple factors, also including physical aspects like 
functional outcome, location of the infarction and use of certain medication.42 This 
multifactorial origin of fatigue could explain why it correlated with virtually all QoL 
domains.
 Only a few studies on this topic in this specific population are available. In a similar 
study, Naess et al. studied QoL in 190 young stroke patients (<50 years) after a mean 
follow-up of 6.0 years using the Short Form (36) Health Survey (SF-36).31 They found 
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significantly lower scores on the subscales physical functioning, general health and social 
functioning in young stroke patients in comparison to controls.8 Since they used a different 
questionnaire to assess QoL it is difficult to compare this directly to our results. However, 
they found that QoL was mainly influenced by depression, fatigue and unemployment 
which is consistent with our findings. 
 Kim at al. assessed QoL in 170 young stroke patients (<45 years) in comparison to 
older stroke patients.40 QoL was significantly better in their younger population. However, 
it is questionable whether elderly patients are a reliable control group when assessing the 
level of QoL. What is interesting however, is that they found that in these young patients 
QoL was mainly influenced by unemployment, motor impairment, aphasia, dysarthria, 
dysphagia and a higher mRS, while in older patients they detected an influence of 
depression and anterior circulation stroke amongst other factors. In contrast, we did not 
find a consistent relationship between a high score on mRS and NIHSS (including motor 
impairment, aphasia and dysarthria) and poor QoL. This might be caused by the relatively 
small number of patients with a score >12 on the NIHSS and a score >2 on the mRS in our 
population, meaning only few patients with moderate-severe disabilities were included. 
Therefore our results cannot be generalized to all young stroke patients, but are 
representative for patients who suffered a stroke of mild severity.
 Knowledge about the influence of psychological factors on QoL is very relevant for 
daily practice. When counselling young stroke patients doctors are likely to pay most 
attention towards motor disabilities. However, our study showed that even in patients 
with little or no motor or other disability, fatigue, depression and anxiety were prominent 
symptoms even years after a stroke at young age and adversely impact QoL. Therefore, 
the presence of these psychological problems should be actively assessed and if possible 
treated, in order to improve QoL. 
 In conclusion, young patients with an ischemic stroke of mild severity often suffer 
from fatigue, depression- and anxiety disorders even after long term follow-up. These 
factors influence QoL in these patients, whereas this could not be demonstrated for stroke 
specific factors. Further investigation is needed to determine whether early screening and 
treatment of psychological problems can improve QoL in young stroke patients.
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Abstract
Background and purpose: Long-term prognosis in terms of cognition in young stroke 
patients is of very important because young stroke patients usually have a long life 
expectancy and rather extensive daily life demands. However, little is known on cognitive 
deficits in these patients. 
We aimed to evaluate cognitive function in young stroke patients (<50 years), after 
long-term follow-up.  
Methods: First-ever young ischemic stroke patients admitted to the St. Elisabeth hospital 
or the TweeSteden hospital, Tilburg, the Netherlands, between January 2000 – December 
2010 were included. Patients with severe aphasia or pre-existent cognitive impairment 
were excluded. Cognitive functioning was assessed using a neuropsychological 
examination  focussing on the following cognitive domains: visual perception, visual- and 
verbal memory, mental speed and executive functioning). Raw scores were compared to 
the scores of 61 controls using a multivariate analysis of variance, with adjustment  for 
education level. 
Results:  The 96 participants (median age at index event 43.0 years; 45.8% male) performed 
worse than controls on the Stroop Color Word Test Part 1 (p<0.001) and on the Symbol 
Substition Task (p<0.001), both assessing mental speed. Patients had significantly lower 
scores on the learning slope of the Word Pairs (p=0.002), assessing verbal memory. 
Patients performed better on the Rey-Osterrieth Complex Figure than controls (p<0.001).
Conclusions: In young ischemic stroke patients mental slowness is present even up to 10 
years after stroke. In counselling these patients doctors should actively try to assess the 
presence of cognitive deficits, also after a long period of follow-up. 
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Introduction
The incidence rate of overall stroke in young patients is 8.7-21.0 per 100,000 person-years.1 
However it is not to be regarded as a rare disease considering up to 12% of all strokes occur 
in adults under the age of 45 years.2 Short-term prognosis is considered more favourable 
compared to older patients, because of lower mortality and better motor function.3 
Recently there is increasing interest in long term mortality and recurrence rate in young 
stroke patients.4,5 However, there is increasing awareness for the fact that prognosis is also 
determined by other factors, like cognitive performance,6,7,8 especially in young stroke 
patients as they are in a period of life they are starting relationships, have to raise children 
or have a job. 
 Most studies in young stroke patients so far evaluated the presence of cognitive 
sequelae in the first year after young stroke, whereas a follow-up of several years would be 
more appropriate in young patients, since they have a longer life expectancy than elderly 
patients.6,7 However, little is known about cognitive function on this longer time window. 
Cognitive problems can have severe impact on psychological and social well-being, 
therefore there should be attention for cognition in counselling these patients. To do so 
adequately, more information about long term cognitive functioning is needed. We 
therefore evaluated the cognitive sequelae of ischemic stroke in young adults up to 
several years after their stroke. 
Methods
Patient selection
All consecutive patients who presented with an ischemic stroke in the St. Elisabeth 
Hospital and the TweeSteden Hospital, Tilburg, the Netherlands, between January 1st, 
2000 and December 31st 2010 were included if they met the following inclusion criteria: (1) 
clinical diagnosis of an ischemic stroke (focal neurological deficit persisting for more than 
24 hours of presumably arterial origin) retrospectively reconfirmed by a stroke-neurologist 
and/or ischemic stroke confirmed by CT and/or MRI and (2) aged between 18 to 49 years 
at the time of the index event. Exclusion criteria were: (1) a history of previous ischemic 
stroke, (2) pre-existent mental disability or severe aphasia at the time of the neuropsychological 
examination or (3) follow-up period less than 1 year. We recruited appropriate cases by 
searching in the Electronic Medical File and existing stroke-databases. 
 Patients were selected if they fulfilled the criteria described earlier. If necessary we 
contacted the general practitioner of these patients to verify whether the patients were 
still alive. Between April 2011 and June 2011, all eligible patients were approached with an 
information letter, in which they were invited to visit the hospital to undergo a neuro-
psychological examination. When patients did not respond to the first letter and second 
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reminder, they were considered to be non-participants. Written informed consent was 
obtained. The Medical Review Ethics Committee of the St. Elisabeth hospital approved the 
study protocol.
Baseline
The following baseline characteristics were obtained retrospectively from patient records: 
stroke severity (National Institutes of Health Stroke Scale (NIHSS)9) and type (according to 
the Oxford Community Stroke Project criteria (OCSP): Total Anterior Circulation Infarction 
(TACI), Partial Anterior Circulation Infarction (PACI), LACunar Infarction (LACI) and POsterior 
Circulation Infarction (POCI)10) and side of infarction. 
Neuropsychological assessment
The neuropsychological examination was executed by a medical student, who was 
trained by a neuropsychologist. The following cognitive domains were examined (tests in 
parentheses): visual perception (copy trial of the Rey- Osterrieth Complex Figure [ROCF]),11,12 
visual memory (immediate and direct recall on the ROCF),11,12 verbal memory (immediate 
and delayed recall, percent retention and learning curve on the Word pair test – a subtest 
from the Wechsler Memory Scale III),13 mental speed (Symbol-Digit Substitution Task,14 
Stroop Color Word Test, parts I and II),15 and executive functioning (Stroop Interference15 
and The Zoo Map test - subtest of the Behavioral Assessment of the Dysexecutive 
Syndrome [BADS]16). Also, education level was noted and divided in three categories (low, 
intermediate, high).
Controls
Controls were recruited from the COMPlaints After Stroke (COMPAS) study,17 a simultaneously 
running study in both hospitals. This study investigates poststroke subjective cognitive 
complaints. The control group consists of a sample from the nonstroke general population 
and is recruited among the relatives and the social networks of participants in the 
COMPAS study. People with pre-existent cognitive decline, a recent history of severe 
 psychopathology and severe physical comorbidity were excluded. These people had 
completed the same neuropsychological tests as our stroke patients. From this control 
group we selected the controls under the age of 57 years at the moment of testing 
to obtain an age-matched control group. 
Statistics
We used Chi square tests and Mann-Withney U tests when appropriate to compare 
baseline characteristics between patients and controls and between participants and 
non-participants. Using multivariate analysis of variance (MANOVA) we compared the raw 
scores on all the cognitive tests between patients and controls, adjusting for sex, age at 
follow-up and education level. Also, we stratified patients for duration of follow-up < 5 
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years and ≥ 5 years) and repeated the analysis. The choice of follow-up period was based 
on the median follow-up period of 5.0 years in the study population. Furthermore, we 
repeated the analysis after excluding the small number of patients (n=5) with a severe 
stroke (NIHSS at baseline of 12 or higher) to see if any findings seen are caused solely by a 
small group of severe stroke patients. Also we used the same analysis to compare patients 
with a mild (NIHSS at baseline below 4) and moderate (NIHSS at baseline between 4-12) 
stroke severity. As these analyses were done for 12 dependent variables, the threshold 
for significance in these analyses was set to a Bonferroni-adjusted p-value of 0.004. 
Normally distributed data are reported as mean (standard deviation), whereas non- 
normally distributed data are reported as median (1.-3. quartiles). All statistical analyses 
were performed using SPSS 19 for Windows.
Results
Study population
In total 96 patients who underwent neuropsychological examination were included in the 
analysis (Figure 1). Participants did not significantly differ from non-participants with 
respect to age at baseline or side of ischemia. Participants were more often male (45.8% vs 
30.3%, p=0.010), less often had a NIHSS>12 at baseline 5.2 vs 17.6%, p=0.003) and smoked 
more often (54.9% vs 33.3%, p=0.001). No differences in other cardiovascular risk factors 
were seen. Baseline characteristics are presented in Table 1. Mean follow-up was 5.0 (SD 2.6, 
range 1-11) years.   
 We included 61 controls. They did not significantly differ from patients in sex and age, 
but patients were significantly lower educated than controls (p<0.001) (Table 1).
Cognitive function
Performances on cognitive tests by patients and controls are presented in Table 2. After 
adjustment for age at the time of the assessment, sex and education level patients 
performed worse than controls on  two tests evaluating mental speed: the Stroop color 
word test Part 1 (p<0.001) and the Symbol Substitution Task (p<0.001). Furthermore, 
patients had significantly lower scores on the learning slope of the Word Pairs (p=0.002), a 
test for verbal memory. Patients showed no deficits in the tests covering visual perception, 
visual memory and executive function. Patients performed better on the ROCF than 
controls (p<0.001). There was no difference in cognitive performance of patients by length 
of follow up duration (p=0.155). 
 When repeating the analysis excluding with a severe stroke (n=5) the results were 
similar. The only difference from the prior findings was that in this analysis also a 
significantly worse performance was seen  on the Stroop part 2 in patients compared to 
controls (62.9 (SD14.7) vs 52.1 (SD7.7), p<0.001). There were no difference in performance 
on the cognitive tests between patients with a mild and a moderate stroke. 
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Discussion
Our study was one of the first to investigate long-term cognitive deficits/performance 
after stroke in young patients. We showed that young ischemic stroke patients are 
impaired in mental speed and in some extent in verbal memory in comparison to controls 
on average almost five years after stroke. Cognitive function was not related to the 
duration of follow-up. 
 The strengths of our study are the long mean follow-up period and the large number 
of young stroke patients included. Furthermore, both hospitals involved in this study are 
collaborating, and together provide stroke care for a wide geographical area in the 
Figure 1   Flow chart of the study population
First-ever young ischemic stroke patients 
between 2000-2010  
n = 340
 
Patients approached by letter  
n = 293 
Deceased: n = 39  
Unknown address: n = 8  
 
Patients prepared to undergo 
neuropsychological assessment  
n = 111 
No response: n = 82  
No informed consent for neuropsychological 
assessment: n = 100  
Study population 
n= 96 
Exclusion for neuropsychological assessment:  
- Severe aphasia: n=5 
- Pre-existent mental disabilty: n=1 
 
Exclusion due to follow-up < 1 year: n = 9  
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Netherlands. It is highly unlikely that young stroke patients in this area would not have 
been presented in one of these two hospitals. Therefore we believe that the young stroke 
patients who were eligible for our study are a representative sample of the young ischemic 
stroke population.
 A limitation of our study is that baseline data were retrospectively derived from the 
patient records. To minimize misclassification all stroke diagnoses were revised by a 
stroke-neurologist and initial imaging was reviewed. Selection bias could have occurred 
by contacting patients by letter. Especially cognitive impaired patients could have had 
problems returning their letter. We tried to limit this possible bias by contacting patients 
twice. This type of selection bias would lead to an underestimation of the cognitive 
deficits long term after stroke rather than an overestimation. Likewise, we were unaware 
Table 1  Baseline characteristics 
Patients  
(n=96)
Controls 
(n=61)
p-value
Median age at baseline in years (1.-3. quartiles) 43.0 (37-47)
Median age at follow-up in years (1.-3. quartiles) 47.3 (42-52) 49.2 (44-54) 0.116
Men, n (%) 44 (45.8) 20 (32.8) 0.146
NIHSS at admission  ≥ 12, n (%) 5 (5.2)
Median NIHSS at admission (1.-3. quartiles) 3 (1-5) (range 0-16)
Type of ischemia, n (%)
     TACI 1 (1.0)
     PACI 31 (32.3)
     LACI 33 (34.4)
     POCI 31 (32.3)
Side of ischemia, n (%)
     Left 47 (49.0)
     Right 42 (43.8)
     Both 7 (7.3)
Education level, n (%) <0.001
     Low 35 (36.5) 7 (11.5)
     Intermediate 44 (45.8) 17 (27.9)
     High 15 (15.6) 37 (60.7)
     Unknown 2 (2.1) 0
Abbreviations: NIHSS: National Institutes of Health Stroke Scale. TACI: total anterior circulation infarction. 
PACI: partial anterior circulation infarction. LACI: lacunar infarction. POCI: Posterior circulation infarction.
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of the reasons why part of the responders did not want to undergo a neuropsychological 
examination. Unfortunately only 96 of the 301 survivors (31.9%) participated in this study. 
It is interesting to realize that participants less often had a severe stroke than non- 
participants This is probably related to higher mortality and disability in patients with a 
severe stroke, limiting participation. Even though we analyzed a group with limited 
severity of their stroke still we detected clear cognitive deficits long term after stroke. 
Also, when stratifying for stroke severity we could not find a difference in long term 
cognitive function based on this parameter. The cognitive deficits we found in our young 
stroke patients were not just driven by the patients with the worst initial stroke however, 
since excluding these patients from the analysis even strengthened our finding that 
stroke patients have an impaired mental speed.
 Also, we had a relatively small group of controls in comparison to the number of 
patients. 
 Controls had a substantially higher level of education, which made it impossible for 
us to transform the raw scores into composite z-scores (transforming the scores of patients 
Table 2  Raw scores on cognitive tests in patients and controls 
Cognitive tests Mean scores (SD) p-value
Patients Controls
Rey Osterrieth Complex figure  
     Copy Median (quartiles) 36 (34-36) 34 (33-35) <0.001*
     Direct recall Mean (SD) 19.5 (6.2) 22.0 (5.7) 0.407
     Late recall Mean (SD) 19.5 (6.0) 21.7 (5.5) 0.321
Word pairs
     Direct recall Mean (SD) 14.9 (8.4) 20.4 (7.4) 0.099
     Delayed recall Mean (SD) 4.6 (2.6) 6.5 (2.0) 0.041
     Learning slope Mean (SD) 2.9 (2.0) 4.5 (2.0) 0.002*
     Percentage recall Median (quartiles) 100 (75-100) 100 (83-100) 0.269
Stroop Color Word Test†
     Part 1 Mean (SD) 52.4 (16.3) 40.5 (7.1) <0.001*
     Part 2 Mean (SD) 65.0 (23.5) 52.1 (7.7) 0.015
     Interference  (part 2-3) Mean (SD) 33.7 (21.1) 27.3 (9.8) 0.125
Symbol Substitution task Mean (SD) 63.8 (18.3) 79.6 (13.5) <0.001*
Zoo map test Median (quartiles) 14.5 (10-16) 16 (11-16) 0.888
† In contrast to the other tests presented, a higher score implies a worse performance on this test.  
* p < 0.004 was considered to be significant.
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to standardized scores in relation to the mean and standard deviation of the control 
group), which would have allowed us to present scores per cognitive domain. Since 
education level is an important confounder when considering cognitive function, we did 
compare all raw test scores adjusting for education level. Thus we could obtain a reliable 
impression of the cognitive deficits in patients. 
 The most prominent finding in our study was the impairment in mental speed in 
patients in comparison to controls. In addition to this patients also had a more limited 
learning curve on the Word Pair test. Although this test is generally used to evaluate verbal 
memory, mental slowness also negatively affects performance since the test is performed 
under time pressure. Patients performed comparable to controls on the other cognitive 
tests, apart from better performance of patients on the copy of the ROCF. In this test no 
time limit was set, which enabled patients to take all the time they needed to make an 
accurate copy of the figure. Together with the willingness to perform the best they can, 
this may have resulted in a better performance in patients than in controls on this task.  
 Two earlier studies described the short-term cognitive functioning after young 
stroke.6,7 Cao et al. detected deficits in reasoning, language comprehension and verbal 
memory in a population of 40 young ischemic stroke patients.6 Malm et al. only included 
patients with an infratentorial infarction (n=24). In their study patients generally performed 
worse than controls in various aspects of cognitive function, especially in tasks concerning 
working memory, the temporary storage of complex information and cognitive flexibility.7 
It is difficult to compare our results with those previously found, since these two studies 
both assessed patients within the first year after stroke and both measured other aspects 
of cognitive functioning than we did. 
 Only one study studied the long term cognitive function after young stroke.8 In 270 
young ischemic stroke patients neuropsychological assessment was performed after a 
mean follow-up of 11.0 years. They found that up to 50% of the patients had a below 
average performance or cognitive impairment. Deficits in processing speed, working 
memory, and attention were most common. This is in line with the mental slowness we 
found in our population. 
 Cognitive function after stroke in elderly patients is a more often studied topic. It has 
been shown in several studies that mental slowness18-20 and impairment in abstraction,18 
mental flexibility18 and working memory7 are highly prevalent among elderly stroke 
patients. In a systematic review of lacunar stroke patients it was shown for example that 
stroke patients have cognitive deficits in all domains, but the most prominent were mental 
slowness and global cognitive impairment.21 Our results are therefore in line with those 
found in elderly stroke patients. 
 Cognitive impairments can have major impact on daily life functioning in these 
young patients. Therefore it is of the utmost importance that doctors treating these 
patients actively assess the presence of cognitive impairment, not only in the first months 
after stroke, but also in the following years. Patients should receive appropriate counselling 
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when cognitive deficits are present, in attempt to minimize the negative effects of 
cognitive impairment on daily life.   
 In conclusion, impairment in mental speed is present in young ischemic stroke 
patients up to 10 years after stroke. This implies that doctors should be alert to the 
presence of cognitive impairment even years after stroke and counsel patients when 
needed. Further research is needed to clarify the role of these cognitive deficits in long 
term functional outcome, quality of life and employment.  
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Potential risk factors for poor outcome 
after young stroke
5
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Abstract
Background and purpose: Our objective is to investigate the influence of cognitive 
performance on long-term functional outcome after IS in young adults aged 18 through 
50 years (young IS). 
Methods: This study is part of a prospective cohort study among 277 stroke survivors 
with a young IS admitted to our department between January 1, 1980 and November 1, 
2010. Functional outcome was assessed during follow-up between 2009-2012 with the 
Modified Rankin Scale (mRS) and Instrumental Activities of Daily Living scale (iADL). Also, 
extensive neuropsychological investigation was performed. Logistic regression was used 
to calculate odds ratios for a poor functional outcome (Modified Rankin Scale >2 or iADL 
<8) for the seven cognitive domains adjudicated for confounders. Cognitive function 
(continuous) as well as cognitive impairment (dichotomous) were studied.
Results: Only decline in working memory (OR 0.3; 95%CI 0.1-0.6) was associated with poor 
functional outcome on the mRS. Except for decline in processing speed (OR 0.5, 95%CI 
0.3-0.8) and working memory (OR 0.4, 95%CI 0.2-0.7) no relation was found with poor 
functional outcome on iADL. Impairment in none of the individual cognitive domains was 
related to long-term functional outcome, although impairment in global cognitive 
function was related to a poor functional outcome on the iADL (OR 4.8, 95%CI 1.7-14.0).
Conclusions: On average 11 years after young IS there was no clear relationship between 
long-term cognitive deficits and long-term functional outcome or iADL, stressing the 
need for further prospective studies with further development of sensitive measures of 
functional prognosis.
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Introduction
Approximately 10% of all strokes occur in young adults (18-50 years)51, affecting about 2 
million young people each year worldwide. These strokes occur in the period of life during 
which people would like to form families, make decisive career moves, and have an active 
social life. In order to live such a life, patients have to regain complex skills after stroke,  not 
only for the months to come, but rather for the years after their stroke. 
These complex skills do not only depend on motor impairment but even more on optimal 
cognitive performance. Recent studies indicate that cognitive performance is impaired 
even decades after a young stroke,52, 53 which might be explained by the widespread, 
diffuse impact of focal lesions on brain networks.54 However, these studies did not take 
the effect on functional prognosis into account. Thus, the relevance of these long-term 
cognitive deficits for functioning in daily life after a young stroke is unclear. 
 To our knowledge no studies exist that investigated the actual effects of cognitive 
performance on long-term functional outcome, apart from one small study in patients 
(n=58) up to 65 years showing no relationship between cognitive function and return to 
work 3 years after stroke.55 However, self-reported memory problems were related to mRS 
and work in a long-term follow-up study of patients with first-ever ischemic stroke up to 
49 years old after more than 11 years.56 
Functional prognosis is of key importance to young stroke patients and it is therefore 
important to identify risk factors. Not only factors that can be treated, but also information 
on determinants that can be used to properly inform patients and their relatives.
 The objective of this study was therefore to evaluate the influence of post-stroke 
cognitive function on long-term outcome after young ischemic stroke (IS) on the 
functional level and also by taking instrumental activities of daily living into account. We 
hypothesized that post-stroke cognitive deficits would impair functional prognosis.
Methods
Patients and study design
This study is part of the “Follow-Up of Transient ischemic attack and stroke patients and 
Unelucidated Risk factor Evaluation”-study (FUTURE study), a prospective cohort study that 
investigates causes and consequences of a young stroke.18 
 Inclusion criteria for the FUTURE study were: all consecutive patients with a transient 
ischemic attack (TIA), IS or intracerebral hemorrhage (ICH), between ages 18 – 50 years, 
admitted to the Radboud University Medical Center Nijmegen between January 1, 1980 
and November 1, 2010. The World Health Organization definition for TIA and stroke was 
used.1, 2 Ischemic stroke was defined as a rapidly evolving focal neurological deficit with no 
other than a vascular cause persisting for more than 24 hours. On basis of radiological 
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findings, stroke was subdivided into ICH and IS. Exclusion criteria of the FUTURE study 
were traumatic hemorrhagic stroke, intracerebral hemorrhage in known cerebral metastasis 
or primary brain tumor, stroke due to cerebral venous sinus thrombosis, intracerebral 
hemorrhage due to ruptured cerebral aneurysm, any subarachnoid hemorrhage or retinal 
infarction. 
 For the present study we only included surviving patients with first-ever ischemic 
stroke, since differences in both pathophysiology and long-term functional outcome15 
precluded combining TIA and ICH patients with IS patients. In addition, the absolute 
numbers of TIA and ICH patients with a poor functional outcome were too low for further 
analysis. 
 Patients were identified through a prospective registry of all consecutive young stroke 
patients which included a standardized collection of baseline and clinical characteristics.18 
The assessment of both the etiology (modified Trial of ORG 10172 in Acute Stroke 
Treatment (TOAST) classification)21 and severity (National Institutes of Health Stroke Scale 
(NIHSS)22 at admission) was done for all cases retrospectively by a validated approach.23, 24 
Cardiovascular risk factors at baseline were defined as a either a history of a risk factor 
(mentioned in medical history or the use of medication) or detected during analysis of the 
stroke as follows: diabetes mellitus as a random blood glucose level >200 mg/dL or 
2 consecutive fasting venous plasma glucose levels of ≥126.1 mg/dL;20 hypertension as 
systolic blood pressure ≥135 mm Hg, diastolic blood pressure ≥85 mm Hg, or both, 
measured after the first week of the index event; and atrial fibrillation when identified 
on an electrocardiogram or during continuous electrocardiographic recording. Recent 
smoking was defined as smoking ≥1 cigarette per day in the year prior to the event. The 
Medical Review Ethics Committee region Arnhem-Nijmegen approved the study and we 
received consent forms from all participants in the study.
Follow-up
Information on vital status was available from the hospital or the municipality registry. 
Patients still alive were invited for follow-up assessment between 1-11-2009 and 1-1-2012, 
including a neuropsychological examination and functional outcome questionnaires 
(cross-sectional design).
Functional outcome 
Functional outcome was measured by the Modified Rankin Scale (mRS).26 This scale ranges 
from 0-6 (perfect health without symptoms to death). The ability to carry out more 
complex activities was assessed with the Instrumental Activities of Daily Living scale 
(iADL).27 This scale assesses a person’s ability to perform tasks such as using a telephone 
and handling finances; scores ranging from 0-8 (low to high function).
 A poor functional outcome was defined as a mRS >2. Whereas we used a common 
cut-off value for poor outcome on the mRS,31 there is no such commonly used cut-off 
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value for the iADL. However, loss of independence on any iADL task is usually regarded as 
an impaired iADL.15, 32 Therefore we have chosen a cut-off value of <8 to indicate poor 
performance on the iADL. 
Cognitive assessment
All participants underwent neuropsychological tests that covered the main cognitive 
domains and which have been previously applied in large-scale epidemiological studies 
on cognition in cerebrovascular disease.57 We used strict instruction protocols to assess 
cognitive performance and the researchers were trained to assess cognitive functioning. 
The following cognitive domains were examined (tests between brackets): Processing 
speed (Symbol-Digit Substitution Task, Abbreviated Stroop Color Word Test, parts I and II), 
Visuoconstruction (Rey-Osterrieth Complex Figure [ROCF] – Copy trial), Working memory 
(Paper and Pencil Memory Scanning Task [PPMST]), Immediate memory (ROCF – Immediate 
recall and the total number of words immediately recalled in the three-trial version of the 
Rey Auditory Verbal Learning Test [RAVLT]), Delayed memory (delayed recall on the ROCF 
and the RAVLT), Attention (Verbal Series Attention Task [VSAT] and Executive functioning 
(Verbal Fluency and Stroop Interference). To account for speed-accuracy trade-off on the 
Stroop test, PPMST and VSAT, composite scores were calculated for these tests [accuracy(%)/
reaction time].58 Stroop Interference was computed by dividing the composite Stroop part 
III score by the mean of the composite scores of parts I and II. To prevent potential bias in 
scoring the ROCF, two researchers independently rated 10% of the complex figures in 
both patients and controls, with high inter-rater reliability using the Spearman’s correlation 
coefficients (Copy: r
s
=0.84; Immediate recall: r
s
=0.96; Delayed recall r
s
=0.94). Detailed 
information on the neuropsychological examination is described elsewhere.18, 52 
Other measures
At follow-up depressive symptoms were assessed with the depression subscale of the 
Hospital Anxiety and Depression Scale (HADS).47 Also, the level of education (range 0-7, a 
higher score indicating a higher education level)59 and recurrent vascular events (any 
recurrent stroke and other arterial events consisting of cardiac disease and peripheral 
artery disease) were assessed. When recurrent events were suspected with the aid of a 
standardized, structured questionnaire, information retrieved was verified by contacting 
the physicians involved. Cardiovascular risk factors were assessed using the same criteria 
as used at baseline. 
Statistical Analysis
The mean raw cognitive test scores (±SD) for each test were calculated. As the Rey 
Complex Figure – Copy trial showed a left-skewed distribution, this variable was 
transformed (e5) to obtain a normal distribution to use in all subsequent analyses.60 For the 
purpose of data reduction, across-domain comparison and statistical considerations, raw 
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test scores were converted to z-scores, using the mean and standard deviation of 146 
matched controls (mean age 48.6 years, range 20.4-76.7 years; 41.8% male), described 
elsewhere.52 Z-scores of tests assigned to the same cognitive domain were averaged and 
were used in all subsequent analyses as composite z-score, or domain score. Higher 
z-scores indicate a better performance. If one test of a particular domain was missing, the 
domain score was based on the remaining tests of that domain (always < 4.9%). The mean 
z-scores of all 7 domains were averaged to calculate a compound score for global cognitive 
function (maximum 2 domains missing). Cognitive impairment was defined as more than 
1.5 SD below the mean of a particular domain score or of the compound score for global 
cognitive function.52
 Logistic regression was performed to quantify the relationship between cognitive 
performance and both poor functional outcome (mRS) and poor iADL performance. 
Z-scores of the cognitive domains were entered separately into a logistic regression 
model, adjusting for sex, age at follow-up, education, NIHSS at admission, recurrent strokes 
(IS or ICH), incident other arterial events, diabetes and/or hypertension at follow-up and 
the HADS depression scale sum score. Secondly, the analysis was repeated entering the 
presence of impairments (yes/no) on the cognitive domains separately into the logistic 
regression model. 
 As the analyses were done for seven distinct cognitive domains, the threshold 
for significance in these analyses was set to a Bonferroni-adjusted p-value of 0.0071. 
We performed all statistical analysis using SPSS 20 for Windows.
Results
Study population
For the present study 277 patients with a first-ever IS were included in the analysis (Figure 1). 
The baseline characteristics of participants, non-participants and patients lost to follow-up 
are presented in Table 1. 
 After a mean follow-up of 11.0 (SD 8.2) years 30 patients (10.8%) had suffered from a 
recurrent IS, none of a ICH and 25 patients (9.0%) from other arterial disease. Poor functional 
outcome was observed in 23 patients (8.3%). A poor outcome as assessed by the iADL was 
observed in 38 patients (13.7%). 
 Missing cognitive domain scores (see table 2) were predominantly due to physical 
disabilities (often due to visual impairments), motivational problems, moderate ability to 
communicate in Dutch, logistic reasons, or symptoms of mild aphasia. At follow-up 53 
patients (19.3%) had a depression sum score > 7, suggestive of depression. 
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Cognitive performance, functional outcome and activities of daily living
Each z-score increase in working memory performance was related to a decreased risk of 
poor functional outcome (OR 0.3; 95%CI 0.1-0.6 per z-score increase). The performance on 
any of the other cognitive domains was not related with functional outcome. (Table 3) 
Each z-score increase in working memory performance (OR 0.4, 95%CI 0.2-0.7 per z-score 
increase) and processing speed (OR 0.5, 95%CI 0.3-0.8 per z-score increase) was related to 
a decreased risk of poor performance on the iADL. The performance on any of the other 
cognitive domains was not related with performance on the iADL. (Table 3)
Figure 1   Flow chart of the study population
277 patients (65.8%) of the possible maximum of 
patients that are available for inclusion
6 severely disabled, excluded 
from participation 
    1  severe psychiatric disorder 
    1  unable to speak Dutch  
    1  blind and deaf   
    1  severe fatigue  
    1  severe aphasia  
    1  severe physical disabilities
421 patients as the long-term 
surviving target study 
1005 patients  
241 TIA patients
14 with a history of stroke  
- 7 with TIA 
- 7 with IS/ICH 
184 deceased
138 refused to participate  
84  lost to follow-up 
61 ICH patients
72
Table 1  Baseline characteristics of ischemic stroke patients 
Participants Non-participants Lost to follow-up
n (% of total) 277 (100) 138 (100) 59 (100)
Mean age at event, years (SD) 40.0 (7.7) 40.1 (8.0) 38.4 (8.9)
Men, n (%) 123 (44.4) 59 (42.8) 28 (47.5)
Median NIHSS at admission (IQR) ‡ 4 (2-8) 4 (2-8) 5 (2-12)
Mean follow-up, years (SD) 11.0 (8.2)
TOAST, n (%)
    Large artery 66 (23.8) 42 (30.4) 15 (25.4)
    Cardio-embolism 26 (9.4) 10 (7.2) 5 (8.5)
    Lacunar 38 (13.7) 16 (11.6) 10 (16.9)
    Other determined 47 (17.0) 33 (23.9) 11 (18.6)
    Multiple 7 (2.5) 3 (2.2) 1 (1.7)
    Undetermined 93 (33.6) 34 (24.6) 17 (28.8)
Cardiovascular risk factors at baseline
    Hypertension 84 (30.3) 46 (33.3) 13 (22.0)
    Diabetes mellitus 17 (6.1) 8 (5.8) 2 (3.4)
    Atrial fibrillation 5 (1.8) 0 (0) 0 (0)
    History of smoking‡ 176 (65.4) 73 (54.5) 40 (69.0)
Recent smoking‡ 143 (51.6) 69 (50.0) 39 (66.1)
Cardiovascular risk factors at follow-up
      Hypertension 173 (62.5)
      Diabetes mellitus 34 (12.3)
      Atrial fibrillation 26 (10.7)
      Recent smoking 78 (28.2)
No significant difference between the overall participants group and patients lost to follow-up tested with 
a Chi-square test and Mann Whitney U-test, respectively. Participants only differed significantly from non- 
participants on prevalence of smoking ever, *p=0.043.
‡In 0.8% of the patients NIHSS (National Institutes of Health Stroke Scale ) at admission, in 2.7% of the patients 
smoking status and in 1.1% of the participants HADS depression score was missing.
+ A Hospital Anxiety and Depression Scale (HADS) sum score > 7 on the depression subset is indicative for the 
presence of depressive symptoms.48
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Table 2  Missing cognitive domain scores 
Cognitive domains Missing values
n (%)
Processing speed 7 (2.5)
Visuoconstruction 8 (2.9)
Working memory 7 (2.5)
Immediate memory 2 (0.7)
Delayed memory 6 (2.2)
Attention 18 (6.5)
Executive function 5 (1.8)
Global cogn. function 7 (2.5)
Table 3   The relation of cognitive function in different domains per z-score  
with poor functional outcome 
Cognitive performance mRS >2 iADL <8
OR (95%CI) p-value OR (95%CI) p-value
Processing speed 0.58 (0.34-1.00) 0.051 0.50 (0.33-0.75) 0.001*
Visuoconstruction 0.93 (0.57-1.51) 0.765 1.03 (0.68-1.54) 0.905
Working memory 0.26 (0.11-0.59) 0.001* 0.39 (0.22-0.69) 0.001*
Immediate memory 0.98 (0.51-1.89) 0.951 0.93 (0.55-1.56) 0.776
Delayed memory 0.72 (0.34-1.42) 0.342 0.72 (0.43-1.22) 0.225
Attention 1.08 (0.55-2.10) 0.829 0.62 (0.37-1.04) 0.072
Executive function 0.75 (0.45-1.27) 0.283 0.65 (0.42-1.00) 0.048
Global cogn. function 0.45 (0.19-1.05) 0.063 0.40 (0.20-0.80) 0.010
Z-scores of the cognitive domains were entered separately into a logistic regression model, adjusting for sex, 
age at follow-up, education, NIHSS at admission, recurrent strokes, incident other arterial events, diabetes and/
or hypertension at follow-up and sum score on the depression scale of the HADS. 
*The threshold for significance in these analyses was set to a p-value of 0.007 based on Bonferroni correction.
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Cognitive impairment, functional outcome and activities of daily living
The presence of impairments on any of the individual cognitive domains did not 
significantly influence functional outcome or performance on the iADL, although 
impairment of global cognitive function was associated with poor iADL performance (OR 
4.8, 95%CI 1.7-14.0). (Table 4)
Discussion
Apart from the effect of working memory performance, we found no relationship 
between cognitive performance and worse functional outcome in patients who 
experienced a young stroke on average 11 years ago. In addition, apart from worse 
performance on processing speed and working memory tasks no relationship was found 
with poor performance on the iADL either. An impairment in global cognitive function 
was associated with a poor outcome on the iADL, but the presence of cognitive 
impairment in any of the individual cognitive domains was not related to functional 
outcome nor to iADL performance.
 Strengths of our study were the prospective and single centre design, which allowed 
us to collect information systematically and uniformly both at baseline and follow-up, 
thereby reducing the risk of information bias. Furthermore, our study had one of the 
longest follow-up durations reported. 
Table 4   The relation of cognitive function in different domains for presence of 
impairment (per z-score) with poor functional outcome 
Cognitive impairment mRS >2 iADL <8
n (%) OR (95%CI) p-value OR (95%CI) p-value
Processing speed 91 (33.7) 1.44 (0.33-6.22) 0.627 3.30 (1.17-9.35) 0.025
Visuoconstruction 54 (20.1) 0.97 (0.22-4.20) 0.968 1.54 (0.46-5.15) 0.487
Working memory 83 (30.7) 7.52 (1.56-36.27) 0.012 3.18 (1.20-8.45) 0.020
Immediate memory 66 (24.0) 1.52 (0.40-5.83) 0.540 0.71 (0.25-2.04) 0.528
Delayed memory 59 (21.8) 1.56 (0.43-5.70) 0.500 0.91 (0.33-2.50) 0.855
Attention 61 (23.6) 1.43 (0.34-6.02) 0.623 1.92 (0.72-5.15) 0.195
Executive function 66 (24.3) 1.13 (0.33-3.95) 0.843 1.73 (0.66-4.56) 0.268
Global cognitive function 88 (32.6) 4.53 (1.04-19.77) 0.037 4.83 (1.66-14.03) 0.004*
Presence of impairments on the cognitive domains (dichotomous) were entered separately into a logistic 
regression model, adjusting for sex, age at follow-up, education, NIHSS at admission, recurrent strokes, incident other 
arterial events, diabetes and/or hypertension at follow-up and sum score on the depression scale of the HADS. 
*The threshold for significance in these analyses was set to a p-value of 0.007 based on Bonferroni correction.
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 However, there are some limitations. Although non-participants did not differ in 
baseline characteristics from participants, apart smoking habits, it is likely that functional 
outcome as well as cognitive sequelae influenced whether patients participated or not. 
Although non-participants most likely limit the range of both cognitive performance and 
the functional outcome, we consider it unlikely that the relationship between the two 
would be different than in participants. Secondly, cognitive impairment was assessed on 
average 11 years after stroke. We cannot exclude that cognitive performance in the first 
weeks or months after stroke would have a stronger association with long-term functional 
outcome, since we did not perform a neuropsychological examination in the first period 
after stroke. Finally, co-morbid conditions could have influenced both cognition and 
functional outcome in our population. These would be comorbidities that are present 
during the years after a stroke at young age and apparently are part of life after young 
stroke. Thus, we find it unlikely that the presence of comorbidities in our population would 
influence the generalisability of our results. 
 The patients analyzed in this follow-up study were young patients after a first-ever 
ischemic stroke (mild-severe), who were capable of undergoing neuropsychological 
testing months to years after their index event. Women are overrepresented in comparison 
to other young stroke cohorts, in which the male sex dominated at inclusion and was 
represented in 58%, 54.1 % and 59.2% in southern, central and northern European cities, 
respectively.16 This may limit the external validity.
 In addition to cognitive performance we were specifically interested whether patients 
who have the more severe cognitive sequelae after stroke are at an increased risk of 
having a poor functional outcome. In the healthy population variations in cognitive 
performance are common, which in most cases are not associated with pathology. 
Dichotomizing the data from cognitive testing distinguishes between normal and 
diminished cognitive function. Although we cannot be sure that the detected cognitive 
impairment is due to the stroke itself, we consider this the best possible way too minimize 
the effects of normal fluctuations in cognitive function on functional outcome.
 The mRS is one of the most used functional outcome scales in stroke patients,61 but a 
potential limitation is that it is mainly based on motor function.26 We could not detect a 
relationship between cognitive impairment and a poor functional outcome as assessed 
with the mRS in young IS patients. However, by operationalizing cognitive impairment as 
a MMSE < 24, others found it associated with a poor functional outcome in elderly stroke 
patients.62 A possible explanation for the lack of relationship between the mRS and 
cognition in our population, might be that functional outcome, as assessed with a scale 
predominantly based on motor function, does not necessarily reflect all aspects of every 
day performance in young stroke patients. Also the mRS is not a very sensitive scale. 
Despite a wide range of differences in cognitive performance in the healthy population, 
most of them will be independent in daily life, with no variation in mRS scores. 
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 In addition, the iADL scale was used as a more sensitive measure of daily life 
functioning.35 A decline in working memory and processing speed affected iADL 
performance. These domains are typically involved in post-stroke cognitive sequelae and 
are present in a substantial proportion of patients after (young) stroke.52, 63, 64 However, 
impairment on these domains was not related to functional outcome (as was none of the 
other individual domains), although there is an association between impairment in global 
cognitive function and a poor outcome on the iADL. A possible explanation for these 
findings is that although the iADL is more sensitive to detect problems in complex social 
skills than the mRS, it still only involves eight basic daily life tasks. Probably only severe 
cognitive problems would interfere with these tasks. Also, important aspects of everyday 
functioning that are relevant especially for younger adults, such as vocational performance, 
academic achievements or more complex everyday tasks like computer skills are not 
covered in this scale. The more subtle sequelae young patients experience long after their 
stroke, can be expected to hamper exactly these types of activities. Hence, the lack of 
relationship seen between cognitive impairment and functional outcome after young 
stroke is likely caused by the insensitivity of the commonly used functional outcome 
measures.
 In the general aging population65, 66 as well as in patients with Alzheimer’s disease or 
mild cognitive impairment67 an association between executive function and iADL 
performance has been described. There are similar findings in elderly patients with heart 
failure,68 possibly related to smaller grey matter volume in this population.69 In contrast, in 
chronic dialysis patients no clear association could be detected between objective 
cognitive deficits and iADL performance.32 However, these studies are difficult to compare, 
because the measures used for cognitive and iADL assessments differ and the assumed 
underlying pathophysiological mechanisms depend on the underlying disease. 
 When asked to identify their top 10 research priorities after stroke, both patient and 
health-care professionals particularly mentioned psychosocial consequences related to 
life after stroke of utmost importance.10 We therefore feel that the results provided by our 
study influence clinical practice as it allows for an even better information of patients after 
stroke and their care givers. Providing patients and relatives with information is an 
important aspect of clinical practice.
 Our results do not support an association between long-term cognitive impairment 
and long-term functional outcome, even on average 11 years after stroke in young adults, 
although we cannot exclude that cognitive function is related to other measures of poor 
functional prognosis, like the high rate of unemployment among young stroke patients70 
or quality of life. In the absence of more sensitive iADL measures, a neuropsychological 
evaluation may provide important information about cognitive performance that is 
relevant for more complex everyday activities. However, the possible consequences of 
post-stroke cognitive impairment should be interpreted with caution, particularly since, 
although an association between working memory and processing speed performance 
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and functional outcome is seen, no clear and consistent relationship is seen between 
cognitive impairment across the various domains and long-term outcome using the 
conventional scales. This stresses the need for further prospective studies with shorter 
inclusion times and serial follow-ups concerning cognitive and other, more sensitive, 
functional measurements and information about work and other social function.

Kidney dysfunction and the risk of  
mortality and incident vascular events 
after young stroke 
Published as
Synhaeve NE, van Alebeek ME, Arntz RM, Maaijwee NA, Rutten-Jacobs LC, 
Schoonderwaldt HC, de Kort PL, van der Vlugt MJ, van Dijk EJ, Wetzels JFM, de Leeuw FE. 
Kidney dysfunction increases the risk of mortality and incident vascular events in young 
stroke patients: the FUTURE Study.
Cerebrovascular Diseases 2016;42:224-231.
5.2
80
Abstract
 
Background and objective: In about 30% of young stroke patients no cause can be 
identified. In elderly patients kidney dysfunction has been suggested as a contributing 
risk factor for mortality as well as stroke. Our objective is to investigate the influence of 
kidney dysfunction on long-term mortality and incident vascular events after stroke in 
young adults aged 18 through 50 years.
Methods: We prospectively included 460 young stroke patients with an ischemic stroke 
or transient ischemic attack admitted to our department between January 1, 1980 and 
November 1, 2010. Follow-up was done between 2014 and 2015. Estimated glomerular 
filtration rate (eGFR) was calculated from baseline creatinine levels and was divided in 3 
subgroups: eGFR<60, 60-120 and >120 ml/min/1.73m2. Cox proportional hazard models 
were used to determine the effect of kidney dysfunction on mortality and incident 
vascular events, adjusting for cardiovascular risk factors. 
Results: An eGFR<60 (HR 4.6; 95%CI: 2.6-8.2) was associated with an increased risk of 
death and an increased risk of incident stroke (HR 4.1; 95%CI: 1.9-9.0) independent of 
cardiovascular risk factors, but it was not associated with other vascular events.
Conclusions: Kidney dysfunction is related to long-term mortality and stroke recurrence, 
but not to incident cardiovascular disease, on average 11 years after young stroke. Our 
findings might be a first step in the recognition of kidney dysfunction as a new risk factor 
for the development of stroke at young age.
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Introduction
In about 30% of young ischemic stroke (IS) patients no cause can be identified despite an 
extensive diagnostic work up.71 Recently, interest has risen in the role of kidney dysfunction 
in the etiology and prognosis of stroke72, 73 since an increased prevalence of kidney 
dysfunction was observed in stroke patients and was related to increased in-hospital 
mortality74 and increased long-term mortality,75-77 although this was foremost in elderly 
stroke patients.78 To date, only one study described a relationship between kidney 
dysfunction and increased long-term mortality and incident cardiovascular disease in a 
young ischemic stroke population, although the relationship between kidney dysfunction 
and incident cardiovascular events was not found to be independent from cardiovascular 
risk factors.79 
 In elderly patients, the traditional held view is that stroke and kidney dysfunction 
share identical traditional cardiovascular risk factors, such as hypertension and diabetes 
mellitus and as such kidney dysfunction could be considered a surrogate marker for 
 cerebrovascular disease, rather than an independent risk factor for stroke. Although these 
traditional risk factors are less prevalent in patients with stroke at young age and they have 
been exposed to these risk factors for a much shorter period of time, it cannot be excluded 
that kidney dysfunction is, even in these young patients, just a surrogate marker of 
cardiovascular disease. However, there are also hypotheses that novel non-traditional risk 
factors, like chronic inflammation and oxidative stress, are involved in chronic kidney 
disease, affecting the cerebral microvasculature, that thereby could lead to stroke.78, 80
 As a first step in clarifying the relationship between kidney function and stroke, at 
young age we wanted to investigate the relationship between kidney function at stroke 
onset, mortality and incident vascular events after stroke in young adults and if so, if this 
relationship would be independent of other cardiovascular risk factors. 
Methods
Patients and study design
This study is part of the “Follow-Up of Transient ischemic attack and stroke patients and 
Unelucidated Risk factor Evaluation”-study (FUTURE study), a prospective cohort study that 
investigates causes and consequences of a young stroke.9 The Medical Review Ethics 
Committee region Arnhem-Nijmegen approved the study. Written informed consent was 
obtained from all patients.
 In short, the FUTURE study comprised all consecutive patients with a transient 
ischemic attack (TIA), IS or intracerebral hemorrhage (ICH), between ages 18 – 50 years, 
admitted to the Radboud University Medical Center between January 1, 1980 and 
November 1, 2010. For the present study we only included patients with first-ever IS or TIA. 
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Exclusion criteria were cerebral venous sinus thrombosis and retinal infarction. To minimize 
bias due to changing diagnostic techniques, the World Health Organization definition for 
TIA and stroke was used.1, 2 Stroke was defined as a rapidly evolving focal neurological 
deficit with no other than a vascular cause persisting for more than 24 hours. On basis of 
radiological findings, stroke was subdivided into ICH and IS. TIA was defined similarly but 
with symptoms persisting for less than 24 hours. 
 Patients were identified through a prospective registry of all consecutive young 
stroke patients that has been maintained at the department beginning in 1978,19 with a 
standardized collection of baseline and clinical characteristics.9
Cardiovascular risk factors at baseline were defined either as a history of a risk factor 
(mentioned in medical history or the use of medication) or as a risk factor detected during 
admission or during the analysis of the stroke, based on the following criteria: diabetes 
mellitus as a random blood glucose level >11.1 mmol/L or 2 consecutive fasting venous 
plasma glucose levels of ≥7.0 mmol/L;20 hypertension as systolic blood pressure 
≥135mmHg, diastolic blood pressure ≥85 mmHg, or both, measured after the first week of 
the index event; and atrial fibrillation when identified on either an electrocardiogram or 
during continuous electrocardiographic recording; dyslipidemia as a cholesterol level >5.0 
mmol and/or LDL >2.5 mmol/l and/or a triglycerides of >2.0 mmol/l. Smoking was defined 
as smoking at least 1 cigarette per day in the year prior to the event. A history of arterial 
disease was defined as a history of cardiac disease, including myocardial infarction and 
surgical treatment for coronary artery disease, or peripheral artery disease.
 Furthermore all patients underwent a neurological examination and brain imaging at 
the time of their index event.18 The assessment of both the etiology (modified Trial of ORG 
10172 in Acute Stroke Treatment (TOAST) classification)21 and severity (National Institutes 
of Health Stroke Scale (NIHSS)22 at admission) was done for all cases retrospectively by a 
validated approach,23, 24 as these scales did not exist at the time when a substantial 
proportion of our patients experienced their qualifying event. 
Follow-up
Information on the vital status was available either from hospital data or via the municipality 
registry. Patients alive were invited for an extensive follow-up assessment between 
November 1, 2009 and January 1, 2012, which included the assessment of incident events 
and the evaluation of cardiovascular risk factors. Subsequently, between August 1, 2014 
and January 15, 2015, TIA and IS patients alive were approached by telephone to assess 
incident events. Of 17 surviving patients (3.7%) information about incident events was 
missing during the follow-up in 2014-2015, therefore in these patients the follow-up data 
from the previous follow-up between 2009-2012 were used.
 The occurrence of incident strokes (IS or ICH) or other arterial disease (cardiac disease 
and peripheral artery disease) was assessed with a standardized, structured questionnaire. 
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Whenever an event was suspected, information was retrieved from the treating physicians 
and subsequently verified by specialists from the appropriate field. If information concerning 
a recurrent vascular event was not sufficient to confirm the diagnosis, it was considered 
as a possible event and not used in the analyses.
Outcome
The primary endpoint was death by any cause. Secondary outcomes included any fatal or 
non-fatal incident arterial event, consisting of fatal or non-fatal incident stroke (IS or ICH) 
and fatal or non-fatal other incident arterial disease (cardiac disease, including myocardial 
infarction, coronary artery bypass grafting and percutaneous coronary intervention for 
coronary artery disease, and peripheral artery disease).8 
Kidney function
We included those patients of whom a creatinine level was available within one month 
after the event (70.1% of the cohort). The median time between the index event and 
creatinine measurement was 1 day (IQR 0-3 days). The Jaffe method was used for creatinine 
measurement until December 2005, thereafter an enzymatic method, calibrated to IDMS 
traceable creatinine, was used. Jaffe values were recalculated to enzymatic values using a 
previously described correction factor.81-83 Estimated glomerular filtration rate (eGFR) was 
calculated from baseline creatinine concentrations, using the chronic kidney disease 
epidemiology collaboration (CKD-EPI) equation.84 For patients undergoing dialysis a 
constant eGFR value of 15 mL/min/1.73m2 was used (n=2). eGFR was divided in 3 
categories: low eGFR (<60 mL/min/1.73m2), normal eGFR (60-120 mL/min/1.73m2) and 
high eGFR (>120 mL/min/1.73m2).79 GFR<60 mL/min/1.73m2 is generally regarded as 
impaired renal function.85 Also, it is suggested that a GFR>120 mL/min/1.73m2 is related to 
an unfavorable outcome.86 An eGFR>120 mL/min/1.73m2 can be regarded as hyperfiltra-
tion which could be a sign of early kidney disease.86 However, a high eGFR can also be 
caused by comorbidity.
Statistical Analysis
Univariate analysis was done to compare patients with a eGFR<60, 60-120 and >120 mL/
min/1.73m2 on stroke subtype (TIA or IS), age, sex, cardiovascular risk factors and TOAST 
classification using Chi-square tests or Fisher’s exact tests when appropriate for categorical 
variables and ANOVA or Kruskal-Wallis tests for (non-)parametric continuous variables. 
Survival plots were made for cumulative mortality, incident arterial events, incident stroke 
and other arterial disease were stratified on kidney function. Patients who died within 30 
days after the index stroke were regarded as fatal cases and were therefore excluded from 
the mortality analysis.9 To ensure that the provided plots were reliable for all subgroups, 
survival plots were curtailed at 15 years.87 Patients who did not reach an endpoint before 
follow-up ended were censored. 
84
 Cox proportional hazards models, adjusted for age, gender, the presence of 
hypertension, diabetes mellitus and/or a history of arterial disease were used to calculate 
the relative risks for death and any fatal or non-fatal incident arterial event for patients with 
a low eGFR (<60 ml/min/1.73m2) compared to patients with a normal eGFR (60-120 ml/
min/1.73m2) as the reference group. Patients with a high eGFR (>120 ml/min/1.73m2) could 
not reliably be compared with patients with a normal eGFR on the occurrence of incident 
events, since the lines in the corresponding survival plots cross. This means that the 
assumption that the effect of the different variables on the outcome are constant over 
time (proportional hazards assumption) were not met, which is essential for a cox 
proportional hazard model. In addition, we repeated these analyses stratified by time of 
admission (<1990, 1990-2000, >2000), to evaluate the effect of changes in diagnostic 
work-up and treatment over time. Also, we repeated the analysis including only those 
patients who had a creatinine level available within 1 day after their index event.
 At young age mean GFR is substantially higher than at older age, which could lead to 
underestimation of young patients with impaired kidney function because their eGFR can 
be above 60 mL/min/1.73m2, while still having a substantially lower eGFR than would be 
expected on the basis of their age. Therefore, we analyzed our data by dividing the eGFR 
in three other categories (below the fifth percentile (p5), above the 95th percentile (p95) 
and between p5-p95 of the expected eGFR of the corresponding age group based on 
a previous validation study of the CKD-EPI equation in our hospital).82 Furthermore the 
analysis was repeated including only patients with an IS. P<0.05 was considered significant. 
The statistical analysis was done using SPSS 20 for Windows.
Results
Study population
Of the 809 eligible patients, 153 refused to participate and of 196 patients baseline 
creatinine levels were unavailable resulting in 460 patients (322 IS, 138 TIA) with a first ever 
stroke in the current analysis. Compared to participants, patients who refused to participate 
were slightly younger (39.1 vs 40.7 years, p=0.008); no other differences in demographics 
or stroke characteristics were found. Compared with patients with available baseline 
creatinine levels, patients without this information were slightly younger (39.6 vs 41.2 
years, p=0.010) and had less severe strokes (median NIHSS 2 vs. 3, p<0.001); no differences 
in any of the other baseline characteristics were found. The baseline characteristics of 
the study population are presented in Table 1. 
 After a mean follow-up of 11.5 (SD 8.3) years, 115 patients (25.0%) had died of which 
21 patients (4.6%) were case-fatalities. 52 Patients (11.3%) had suffered from a fatal or 
non-fatal recurrent stroke and 59 patients (12.8%) from fatal or non-fatal other arterial 
events. (Table 2) 13 patients (2.3%) had both a recurrent stroke and another arterial event. 
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32 patients (61.5%) had their recurrent stroke at an age <50 years, 14 patients (26.9%) 
between 50-60 years and only 6 patients (11.5%) above 60 years. 
Kidney dysfunction and cumulative risk of mortality
Cumulative risk of mortality in patients with a low eGFR was significantly increased 
compared with the reference (log rank p<0.001). (Figure 2) The point estimate for the 
15-year cumulative mortality was 70% (95%CI: 46-94%) for patients with a low eGFR, 24% 
(95%CI: 18-30%) for patients with a normal eGFR and 30% (95%CI: 12-48%) for patients with 
Table 1  Baseline characteristics 
Total eGFR <60 eGFR 60-120 eGFR >120 p-value*
n (% of total) 460 (100) 29 (6.3) 392 (85.2) 39 (8.5)
IS patients (n, %) 322 (70.0) 22 (75.9) 270 (68.9) 30 (76.9) 0.449
Mean age at event, years (SD) 41.2 (7.6) 42.2 (7.2) 42.1 (6.9) 32.4 (9.3) <0.001
Men (n, %) 218 (47.4) 18 (62.1) 178 (45.4) 22 (56.4) 0.111
Median NIHSS at admission (IQR) 3 (1-9) 4 (1-11) 3 (1-8) 9 (3-15) 0.001
Mean follow-up, years (SD) 11.5 (8.3) 7.2 (7.2) 11.8 (8.3) 11.2 (8.5) 0.009
TOAST (n, %)
     Large artery 107 (23.3) 8 (27.6) 93 (23.7) 6 (15.4) 0.426
     Cardioembolism 65 (14.1) 7 (24.1) 51 (13.0) 7 (17.9) 0.195
     Small vessel 51 (11.1) 5 (17.2) 44 (11.2) 2 (5.1) 0.279
     Other determined 68 (14.8) 3 (10.3) 60 (15.3) 5 (12.8) 0.702
     Multiple causes 10 (2.2) 2 (6.9) 8 (2.0) 0 0.165
     Unknown 159 (34.6) 4 (13.8) 136 (34.7) 19 (48.7) 0.011
Hypertension (n, %) 162 (35.2) 21 (72.4) 132 (33.7) 9 (23.1) <0.001
Diabetes mellitus (n, %) 38(8.3) 5 (17.2) 29 (7.4) 4 (10.3) 0.127
Dyslipidemia (n, %) 272 (80.7) 18 (94.7) 226 (79.0) 28 (87.5) 0.144
Atrial fibrillation (n, %) 9 (2.0) 0 9 (2.3) 0 1.000
Smoking (n, %)‡ 229 (52.4) 11 (45.8) 194 (51.3) 24 (68.6) 0.002
History of arterial events (n,%) 26 (5.7) 3 (10.3) 22 (5.6) 1 (2.6) 0.424
‡5.0% missing data
Abbreviations: eGFR: estimated glomerular filtration rate; IS: ischemic stroke; NIHSS: National Institutes of 
Health Stroke Scale; IQR: interquartile range; TOAST classification: modified Trial of ORG 10172 in Acute Stroke 
Treatment (TOAST) classification
* Chi-square tests or Fisher’s exact tests when appropriate, were used for categorical variables and ANOVA or 
Kruskal-Wallis tests for (non-) parametric continuous variables.
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a high eGFR. Both a low eGFR (HR4.6; 95%CI: 2.6-8.2) and a high eGFR (HR2.6; 95%CI: 
1.3-4.9) were associated with an increased risk of death after adjustment for age, gender 
and cardiovascular risk factors compared with the reference. (Table 3) 
Table 2  Mortality and incident vascular events 
Outcome Total eGFR<60 eGFR 60-120 eGFR >120 p-value*
Death from any cause (n, %) 115 (25.0) 18 (62.1) 85 (21.7) 12 (30.8) <0.001
     < 1 month after event (n, %) 21 (4.6) 3 (10.3) 18 (4.6) 0 n/a
     > 1 month after event (n, %) 94 (20.4) 15 (51.7) 67 (17.1) 12 (30.8) <0.001
Any vascular event (n, %) 98 (21.3) 11 (37.9) 82 (20.9) 5 (12.8) 0.048
Stroke (IS, ICH) (n, %) 52 (11.3) 8 (27.6) 40 (10.2) 4 (10.3) 0.017
Other arterial events (n, %) 59 (12.8) 6 (20.7) 52 (13.3) 1 (2.6) 0.069
Abbreviations: eGFR: estimated glomerular filtration rate; IS: ischemic stroke; ICH: intracerebral hemorrhage. * 
Chi-square tests was used to compare the number of deaths or events between eGFR categories.
Figure 1   Cumulative mortality
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Kidney dysfunction and cumulative risk of incident stroke
Cumulative risk of any incident vascular event in patients with a low eGFR was significantly 
increased compared with the reference adjusted for age, sex and cardiovascular risk 
factors (HR2.5; 95%CI 1.3-4.7). Incident vascular events can be divided in incident stroke 
and other vascular incident events. Cumulative risk of incident stroke in patients with a 
low eGFR was significantly increased compared with the reference (log rank p<0.001). The 
point estimate for the 15-year cumulative risk of incident stroke was 45% (95%CI: 16-74%) 
for patients with a low eGFR, 13% (95%CI: 9-17%) for patients with a normal eGFR and 8% 
(95%CI: 0-18%) for patients with a high eGFR. (Figure 3A) The patients with a low eGFR 
were at increased risk for incident stroke (HR4.1; 95%CI: 1.9-9.0) after adjustment for age, 
sex and cardiovascular risk factors. 
Kidney dysfunction and cumulative risk of incident other vascular events
Cumulative risk of incident other vascular events in patients with a low eGFR was 
significantly increased compared with the reference (log rank p=0.017). The point estimate 
for the 15-year cumulative risk of incident other vascular events was 23% (95%CI 3-43%) for 
patients with a low eGFR, 17% (95%CI: 11-23%) for patients with normal eGFR and 3% 
(95%CI 0-9%) for patients with a high eGFR. However this effect was not statistically 
significant anymore after adjustment for age, sex and cardiovascular risk factors (HR2.1; 
95%CI 0.9-5.0). (Figure 3B) 
Figure 2   Cumulative risk of incident events
A  Cumulative risk of incident stroke B  Cumulative risk of another arterial event
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Stratification of subgroups
The associations found between kidney dysfunction and the risk of mortality, incident 
stroke and incident other vascular events were similar for IS patients separately, when all 
patients are stratified according to the time of their index event (<1990, 1990-2000, >2000) 
and when only including patients of whom a creatinine level was available within 1 day 
after the index event (n=284).
Observed compared to expected kidney function
64 patients (13.9%) had an observed eGFR<p5 of the expected eGFR of which 35 patients 
(54.7%) had an eGFR>60 mL/min/1.73m2, whereas 32 patients (7.0%) had an eGFR>p95 of 
the expected eGFR. 17 patients (43.6%) with an eGFR>120 mL/min/1.73m2 did have a eGFR 
between p5-p95. The cumulative risks of mortality and incident vascular events for 
patients with an eGFR<p5, between p5-p95 and>p95 of the expected eGFR were similar 
to those for patients with an eGFR<60, 60-120 and >120 mL/min/1.73m2, respectively. 
Discussion
We showed that young stroke patients with kidney dysfunction (eGFR<60 mL/min/1.73m2) 
at baseline had a 15-year risk of death and recurrent stroke of 70% and 45% respectively. 
This risk was 4-5 times increased compared to patients with an eGFR in the normal range, 
independent of co-occurring hypertension and/or diabetes mellitus. In contrast, there 
was no increased risk of other vascular events.
Table 3   Risk of all cause mortality and incident vascular events in patients  
with kidney dysfunction 
eGFR < 60 eGFR > 120
HR 95% CI HR 95% CI
Death from any cause 4.6 2.6-8.2 2.6 1.3 -4.9
Any vascular event 2.5 1.3-4.7 n/a*
     Stroke 4.1 1.9-9.0
     Other arterial events 2.1 0.9-5.0
Normal eGFR (60 to 120 mL/min/1.73m2) served as the reference group. Analysis were adjusted for gender, age 
and the presence of hypertension, diabetes mellitus and/or a history of arterial disease. *Since the effect of an 
eGFR >120 mL/min/1.73m2 on the occurrence of incident events was not constant compared to the reference 
group, cox proportional hazard analysis was not performed.
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 Strengths of our study were the prospective and single centre design, which allowed 
us to collect information systematically and uniformly both at baseline and follow-up, 
thereby reducing the risk of information bias. Furthermore, our study had one of the 
longest follow-up durations reported. 
 However, there are also some limitations. First, although baseline creatinine levels 
were available from >70% of all participants, selection bias could have occurred. Baseline 
creatinine levels were most often missing in those who had their initial stroke longer ago. 
A higher proportion of incident vascular events was seen in these patients in comparison 
to participants (respectively 21 vs 11% for incident stroke and 17 vs 13% for other vascular 
events), while there was no difference in mortality. Also the 5-year risk of incident stroke 
was somewhat higher than expected in these patients (14% (no creatinine available) vs. 
22 % (eGFR <60); 6% (eGFR 60-120); 8% (eGFR>120), suggesting that there is an overrepre-
sentation of patients with an incident stroke among the patients of whom we did not 
have a creatinine level available.  
 Secondly, information bias could have occurred by using creatinine levels up to one 
month after the event. Although it has been described that there can be some fluctuation 
in creatinine levels in the first days after a intracerebral hemorrhage 88, we considered it 
unlikely that this time-window would affect the creatinine levels substantially. As expected 
we found similar results when the analysis was limited to only those patients who had a 
creatinine level available within one day after stroke. 
 Furthermore, we are the first to relate the observed eGFR in our patients to the 
expected eGFR (defined by a healthy population) in an additional analysis, taking the age 
and sex of the patient into account to define poor kidney function. Thus we controlled for 
misclassification of young patients with impaired kidney function who did have a eGFR>60 
mL/min/1.73m2 as having a normal kidney function. This additional analysis showed 
similar associations between poor kidney function and the risk of death and incident 
strokes.
 Another possible cause of misclassification could be that the eGFR is based on only 
one creatinine measurement which might not reflect true kidney dysfunction in all cases. 
In some patients the decreased eGFR might be due to other factors like stroke itself such 
as dehydration. However, the possible overestimation of the total number of patients 
having kidney dysfunction, would lead to an underestimation of the effect of kidney 
dysfunction on the endpoints. 
 Previous studies have shown a clear relationship between poor kidney function and 
mortality, albeit in an elderly stroke population. Only one previous study described a 
similar relationship in young stroke patients, however the mean follow up was much 
shorter 89. They described a relationship between mortality and an eGFR<60 mL/
min/1.73m2 and an eGFR>120 mL/min/1.73m2 and mortality similar to our results.79 An 
increased eGFR>120 mL/min/1.73m2 can be regarded as hyperfiltration which could be a 
sign of early kidney disease.90 However, a high eGFR can also be due to a low creatinine 
90
level caused by muscle wasting in patients with physical limitations after stroke (bedridden, 
wheel-chair bound). In these patients increased mortality might be caused by comorbidity 
and might not related to true kidney disease. 
 In the elderly population kidney dysfunction has been independently associated 
with increased risk of incident cardiovascular events after stroke.90-92 The previous 
mentioned study in young stroke patients also investigated the relationship between 
kidney dysfunction and incident arterial events in a young stroke population.79 In contrast 
to our results, this association was not independent of cardiovascular risk factors. Very 
interestingly, we could not establish an association between kidney dysfunction and 
other vascular events independent of hypertension, diabetes mellitus and/or a history of 
vascular events. This suggests an additional pathophysiological mechanism underlying 
the association between kidney disease and incident stroke apart from traditional risk 
factors that does not affect other arteries. A possible explanation for the increased risk of 
incident stroke is that progressive kidney dysfunction provokes increased blood pressures 
through several pathophysiological mechanisms,93 possibly increasing the risk of stroke 
independent of the presence of hypertension at baseline. It can be speculated that the 
heart is less vulnerable to hypertension itself, while the brain and kidney share a similar 
vascular structure with low-resistance exposure of the small vessels to highly pulsatile 
flow and pressure.78 Also, there are hypotheses that novel non-traditional risk factors, like 
chronic inflammation and oxidative stress are involved, affecting the cerebral micro-
vasculature.78, 80
 In conclusion, kidney dysfunction at the time of a young stroke onset is related to an 
increased risk of long-term mortality and stroke recurrence, but not to incident 
cardiovascular disease. This warrants a more intensive follow-up of young stroke patients 
with signs of kidney dysfunction in the early phase. Possibly kidney dysfunction is not only 
a risk factor for poor outcome (increased mortality and increased risk of incident strokes), 
but the clear association between kidney dysfunction and incident stroke seen in our 
young stroke population might be a first step in the recognition of kidney dysfunction as 
a new risk factor for the development of stroke at young age. Also, it can lead to new 
insights in the etiological differences between cardiovascular and cerebrovascular disease. 
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Worldwide, stroke is the second most common cause of mortality and one of the most 
common causes of disability.3 According to the World Health Organization, worldwide 
15 million people suffer a stroke each year. Of these, 5 million die and another 5 million 
remain permanently disabled.94 The risk of having a stroke more than doubles each 
decade after the age of 55,95 consequently nearly three-quarters of all strokes occur in 
people over the age of 65. However, 1 out of 10 strokes occur in patients between 18 and 
50 years.51 These are referred to as ‘stroke in young adults’ or ‘young stroke’.
 Young stroke occurs in the period of life during which people might like to start 
families, to raise children or to make decisive career moves. In general, at this age people 
are active participants in the community. Consequently, uncertainty about their long-term 
functional outcome may affect patients’ choices in personal and occupational issues. 
Undoubtedly this uncertainty has a huge impact on the perceived quality of life. Apart 
from increasing knowledge about long-term prognosis after young stroke in general, it is 
also needed to identify important determinants of outcome. It is not only important to 
ascertain those factors which might be amenable for treatment, but also to provide 
information on other determinants to patients and their relatives because they are very 
relevant in the process of (shared) decision making. In this thesis we investigated the 
long-term prognosis after stroke in young adults and aimed to identify determinants 
which best predicted this long-term prognosis.
 Chapter 2 of this thesis describes the long-term functional outcome after a stroke at 
young age in the FUTURE cohort. In chapter 2.1 we showed that even ten years after a 
young stroke about one out of eight survivors with an IS or ICH (12.9%) was not able to 
function independently. In TIA patients, who by definition have no residual impairment, 
this was one out of fifteen (6.5%) survivors. Chapter 2.2 shows that the proportion of 
patients who cannot function independently substantially increased over the years. After 
extending the follow-up duration to an average of 14 years after a young stroke, almost 
one out of five long-term IS survivors (18.8%) and almost one out of ten (9.8%) TIA patients 
were not able to function independently anymore. Overall, 11.5% of TIA and IS patients 
deteriorated from good to poor functional outcome between the first (2009-2011) and 
second (2014-2015) follow-up. In contrast, only 1.3% of patients improved from poor to 
good functional outcome. The strongest predictor of poor long-term functional outcome 
was the female sex and the severity of the initial stroke. Women had a two to threefold 
higher risk of a poor outcome than men. 
 In chapter 3 of this thesis the long-term quality of life (QoL) after a stroke in young 
adults was addressed in the young stroke cohort derived from the hospitals in Tilburg. 
There were no major differences in the QoL between young stroke patients and controls 
after long-term follow-up (mean 4.9 years). Depression and fatigue were both highly 
prevalent even many years after stroke at young age. Multiple regression analysis showed 
that especially fatigue and to a lesser extent depression, anxiety and unemployment 
negatively influenced the QoL. In contrast, variables related to stroke severity like the 
96
severity of the neurological deficits (NIHSS) at admission and mRS at follow-up were not 
related to the QoL. 
 Chapter 4 of this thesis describes the long-term cognitive deficits after stroke in 
young patients. We showed that young ischemic stroke patients are impaired in mental 
speed and to some extent in verbal memory in comparison to controls, on average almost 
five years after stroke. 
 In chapter 5 of this thesis we investigated potential determinants of poor outcome 
after a young ischemic stroke. Chapter 5.1 showed that the presence of cognitive 
impairment in any of the individual cognitive domains (scores <1.5 SD of controls) was not 
related to functional outcome nor to iADL performance in patients who experienced a 
young stroke on average 11 years ago. In chapter 5.2 we showed that young stroke 
patients with kidney dysfunction (eGFR <60 mL/min/1.73m2) at baseline had a 15-year risk 
of death and recurrent stroke of 70% and 45% respectively. This risk was 4-5 times increased 
compared to patients with an eGFR in the normal range, independent of co-occurring 
hypertension and/or diabetes mellitus. We could not establish an association between 
kidney dysfunction and other arterial events independent of hypertension, diabetes 
mellitus and/or a history of arterial events. 
Conclusion
The long-term outcome in young stroke patients is not favourable. This is in contrast with 
the general opinion in neurologists, which is based on studies describing lower short-term 
mortality rates in young stroke patients compared to older patients.96 A substantial 
proportion of patients, even in the long run after stroke (on average 14 years after stroke), 
stays dependent in daily living, despite their young age. This especially holds true for 
women and patients with severe neurological deficits at admission. Fatigue and depression 
after stroke are associated with a lower quality of life. Therefore, it is important that health 
care professionals actively assess the presence of these symptoms. Unexpectedly, in 
contrast, the effect of post-stroke cognitive disorders on the daily life after a stroke at 
young age is less clear. A new, preliminary insight is the association between kidney 
dysfunction and the occurrence of recurrent strokes after a young stroke.
 The results of these studies enable health care professionals to give patients and their 
relatives more accurate information on the long-term functional prognosis after a stroke 
at young age. More studies are needed to develop personalized predictive models to 
counsel young stroke patients about their future perspectives and to unravel the patho-
physiological mechanisms that are responsible for the influence of specific determinants 
of prognosis, such as the female sex and kidney dysfunction. 
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Methodological considerations
The studies presented in this thesis are based on two separate cohort studies. Chapter 2 
and 5 are based on the Follow-Up of Transient ischemic attack and stroke patients and 
Unelucidated Risk factor Evaluation (FUTURE)-study, a prospective cohort study that 
investigates causes and consequences of a young stroke. Chapter 3 and 4 are based on a 
retrospective cohort of young ischemic stroke patients seen in the two hospitals in 
Tilburg, the Netherlands. In the following paragraphs the methodological considerations 
for each study will be discussed.
Internal validity
The internal validity of a study (the extent to which a causal conclusion based on a study 
is warranted) is based on both systematic errors and random errors. Systematic errors can 
be divided in selection bias, information bias and confounding. Random errors are due to 
the precision of the study.97 
Selection bias
Selection bias occurs when the relation between the determinant and the outcome 
differs between participants and potentially eligible non-participants.97 In both young 
stroke cohorts we have done all efforts to include all eligible patients and monitor the 
cohort for a complete follow-up. However, like all studies, it is likely that not all eligible 
patients were identified, for instance because patients had died before admission to the 
hospital or because stroke-related deficits were so minor or atypical that they were not 
diagnosed as such. Unfortunately, it is impossible to determine to what extent this type of 
selection bias has occurred. However, it seems likely that patients with minor strokes were 
more often unidentified than patients with severe strokes. Therefore in our results there 
could be a slight overestimation of the proportion of young stroke patients with a poor 
long-term functional outcome. 
 In addition, a part of the patients were either lost-to follow up in the years thereafter 
or did not want to participate in particular substudies, leading to a selective lost-to- 
follow-up. We have compared baseline characteristics between participants and non- 
participants to get insight in potential selection bias. In the Tilburg cohort we noticed that 
participants had less severe strokes than patients who refused to participate. Therefore 
the results, as far as quality of life and long term cognitive outcome are considered, can 
best be generalized to young stroke patients with mild to moderate stroke severity, but 
not to patients with severe strokes. In the FUTURE study population no prominent 
differences in baseline characteristics between participants and non-participants were 
noted. This difference could be due to the difference in study protocol between both 
cohorts. The patients in the FUTURE cohort were invited to undergo a very extensive 
study protocol, including a MRI-scan, blood tests and electrocardiogram, whereas the 
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study protocol in the hospitals in Tilburg was more limited. Possibly more patients, 
especially those with severe sequelae, considered the extensive medical examination as a 
personal advantage, not just related to the altruistic research purposes.
Information bias
Information bias results from measurement error of the determinant or of the outcome, 
possibly leading to misclassification.97 The prospective and single centre design of the 
FUTURE study allowed us to collect information systematically and uniformly both at 
baseline and follow-up, thereby reducing the risk of information bias.9 For all patients who 
were included in the hospitals in Tilburg the clinical diagnosis of ischemic stroke was ret-
rospectively confirmed by a stroke neurologist to avoid misclassification. 
 Especially the diagnosis of TIA is vulnerable to misclassification, since this diagnosis is 
mainly based on the symptoms reported by the patients or relatives in contrast to an 
imaging based diagnosis. This could lead non-cerebrovascular diseases, with a completely 
different prognosis, being classified as a TIA. In one study, we used a mixed population of 
young TIA and IS patients to show an association between kidney dysfunction and 
recurrent strokes. To limit the effects of possible misclassification of TIA patients we 
repeated the analysis including IS patients exclusively, which showed similar results. 
 Another potential misclassification in this specific study may be due to the fact that 
classification was based on one single eGFR value. This may not reflect true kidney 
dysfunction in all cases. In some patients the decreased eGFR might be due to other factors 
apart from stroke such as dehydration, leading to the possible overestimation of the total 
number of patients having kidney dysfunction. This type of bias would lead to an under-
estimation of the effect of kidney dysfunction on the endpoints, because in the ‘kidney 
dysfunction’-subgroup there could have been patients included without true kidney 
dysfunction. In addition, the methods for measuring the creatinine concentration in blood 
have changed over time. To avoid information bias due to this technical change we applied 
a correction for the type of creatinine essay used. In conclusion, we consider the association 
found between kidney dysfunction and the increased risk of recurrent strokes still plausible.
Confounding
Confounders are variables that correlate with both the determinant and the outcome, but 
that are not within the causal chain.97 It is necessary to control for potential confounders to 
retain internal validity. As an example, when looking into the association between 
cognitive function and functional outcome the general feeling is that the severity of the 
initial stroke would have an effect on both the functional outcome of the patient and on 
the potential cognitive deficits. By adding the initial stroke severity to the multivariate 
model we tried to exclude the possibility of finding a strong effect of cognitive dysfunction 
on poor functional outcome, whereas the true association exists between stroke severity 
and poor functional outcome.
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 In all the risk models used in this thesis we have controlled for known or suspected 
confounders, like age, sex and cardiovascular risk factors. Also, we took specific confounders 
into account for specific outcome measures, for instance education level as a confounder 
for cognitive function. Our choice of potential confounders was based on information 
from previous studies and/or findings in our own univariate analysis. 
Precision
Precision of a study is determined by the degree of absence of random error (fluctuations 
around a true value). The random error is inversely correlated to the size of the study.97 
Firstly, therefore cohort sizes should be considered. The FUTURE cohort is one of the 
largest in the field. A limitation is the small number of ICH and TIA patients included, 
however, still it is the largest “young ICH/TIA” sample with long-term follow-up so far. We 
chose to concentrate on the descriptives of this subgroup and did not take this subgroup 
into account for further analysis considering the high risk of random error. Although the 
cohort of young ischemic stroke patients from the hospitals in Tilburg is smaller than the 
FUTURE cohort, there is still a substantial number of patients included, enabling us to 
present results with acceptable confidence intervals.
 Secondly, precision is also related to the methods we chose to determine the specific 
outcomes measures. For instance, we used a very extensive battery/panel of cognitive 
tests, using multiple tests per cognitive domain. In addition, all cognitive tests were done by 
a trained researcher. Therefore we consider the precision of our cognitive data very high. 
In contrast, whereas the mRS questionnaire was done in a standardized way, the mRS itself 
is quite a global scale, only consisting of 6 possible outcome measures. Therefore we did 
not consider this functional outcome measure to be very precise. For this reason we chose 
to analyse the mRS as a dichotomized value, using a very clear cut-off point based on the ability 
to walk unaided by another person. Other outcome measures, like recurrent vascular 
events, were not only obtained by questionnaires, but also confirmed by a neurologist 
and cardiologist in order to avoid misclassification and thereby maximizing precision. 
External validity
The external validity is the extent to which the results of a study can be generalized to 
other situations and to other people.97 The FUTURE study is a single center study performed 
in a university hospital, which has a wide catchment area for stroke. Young stroke patients 
usually visit a university hospital at some point during the months after their stroke to 
undergo more extensive stroke analysis. For this purpose a special outpatient clinic is 
available in the Radboud University Medical Center for the analysis and counselling of 
young stroke patients. The Tilburg cohort is composed out of patients from the two 
hospitals in Tilburg that collaborate and together provide stroke care for a large 
geographical area in the Netherlands. We considered it highly unlikely that young stroke 
patients in this area would not have been referred to one of these two hospitals. 
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 To get an impression of the external validity of our data we compared both our 
young stroke cohort to the information available from epidemiological studies. The most 
extensive information is available from the 15 cities young stroke study by Putaala et al. 
The sex and age distribution of the FUTURE cohort is slightly different than would be 
expected from this study. Our initial cohort consisted of 1005 patients (independent of 
death or follow-up); 244 patients aged between 18-35 years (84 men, 160 women) and 761 
patients were between 35 and 50 years of age (386 men, 375 women). The proportion of 
women is slightly overrepresented in our study population and can be explained by the 
inclusion of relatively many young (<35 years) patients, an age category in which women 
are usually overrepresented. (See figure below) This is likely due to overrepresentation of 
female sex-specific risk factors or conditions in this age group such as oral contraceptive 
use, pregnancy or postpartum period or migraine. The female predominance in our study 
population is in line with the young age of the stroke patients included.16 In addition, the 
initial stroke severity as measured by the NIHSS in our cohort is in line with that of another 
large young stroke cohort which published NIHSS at admission in detail.98 Therefore, we 
consider it likely that the FUTURE cohort is a good representation of young stroke patients 
in general. 
 The young stroke cohort from the hospitals in Tilburg is similar to the FUTURE cohort 
with respect to age and sex of the young stroke patients. In addition, only few patients 
with moderate to severe disabilities (mRS >2) participated in the further analysis. Therefore 
the results from these studies cannot be generalized to all young stroke patients, but are 
representative for patients who suffered a stroke of mild severity. 
Putaala J et al. Stroke. 2012;43:2624-2630
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General discussion of main findings
Long term prognosis
Long-term functional outcome
The general feeling about the prognosis after stroke in young adults is that it is more 
favorable than in elderly patients. However, in this thesis we showed that on average 14 
years after a young ischemic stroke almost one out of five long-term survivors (18.8%) was not 
able to function independently. In surviving TIA patients almost one out of ten (9.8%) could 
not function independently. In previous studies, poor functional outcome in young IS 
patients ranged from 3% to 7% after mean follow-up duration between 4 and 12 years.29, 33, 34 
These studies showed a better outcome than seen in IS patients in our study. This could 
be explained by the inclusion of older patients (up to 50 instead of 45 years of age) and the 
longer follow-up duration in our study. Furthermore, in these previous studies functional 
outcome was measured only by either the mRS or the Glasgow Outcome Scale, which are 
commonly used, but are rather global scales for outcome. In contrast to the mRS, iADL 
takes into account the ability to perform very specific tasks relevant for living independently. 
Sex-differences
Interestingly, women had a two to threefold higher risk of a poor outcome than men after 
a stroke at young age. The sex-difference in long-term functional outcome after stroke has 
previously been described in the elderly stroke population.14, 17, 37 It is assumed that the 
sex-differences could be (partially) explained by a higher age, poorer prestroke 
functionality, more comorbidities, a tendency to suffer from more severe strokes and less 
social support in women in comparison to male stroke patients.14, 17, 37 A possible explanation 
also includes a higher prevalence of poststroke depression in women than in men. 
 There is also ongoing research to identify biological mechanisms clarifying the 
sex-differences in the prognosis of stroke patients, which mainly focuses on the role of sex 
steroid hormones. Estrogen, testosterone and progesterone affect discernable physiologic 
functions of the cerebral circulation and have impact on diverse pathophysiologic 
processes of which the final clinical effect is yet unclear. Estrogen promotes blood flow by 
decreasing vascular reactivity while testosterone has opposite effects. Both are involved in 
the development of atherosclerosis, where inconsistent effects are reported.37 In addition 
to the hormone-regulated mechanisms, several aspects of the sex differences observed 
following stroke appear to be independent of direct hormone action. The contribution of 
the differences in chromosomal makeup of the organism  between the sexes is increasingly 
being recognized as a potential source of the sex difference.99 A recent study suggests 
that sex-specific expression of genes related to poststroke immune responses, 
inflammatory responses and cell death responses may be responsible for differences 
between women and men.100 However, so far studies focus mainly on the mechanisms 
underlying the sex-differences in the prognosis of elderly stroke patients. 
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Long-term quality of life 
Interestingly, we did not show a consistently diminished QoL years after stroke in young 
patients. Most likely the equal QoL in both patients and controls found in our population 
is due to our choice to adjust for depression and anxiety, since both were significantly 
more prevalent in patients than in controls and are known to have a negative influence on 
QoL. We added depression and anxiety to our multivariate model to avoid confounding. 
However, by doing so, the detection of  a clinically relevant difference in quality of life 
between patients and controls may have been diminished. 
 As expected, we did detect a very strong and consistent relation of fatigue with QoL 
and to a lesser extent with depression, anxiety and unemployment, whereas in contrast to 
our hypothesis, no relationship between QoL and motor performance-related variables 
(NIHSS, mRS) was seen. The contrast between the effect of psychological factors and 
motor-related variables might be influenced by the relatively small number of patients 
with a score >12 on the NIHSS and a score >2 on the mRS in our population, whereas the 
psychological factors (depression, anxiety, fatigue) were highly prevalent in our study 
population. 
 Two previous studies assessed the quality of life in young stroke patients.31, 40 In one 
of these QoL was mainly influenced by depression, fatigue and unemployment,31 which is 
consistent with our findings. However, in contrast to our results, in the other study QoL 
was mainly influenced by unemployment, motor impairment, aphasia, dysarthria, 
dysphagia and a higher mRS.40 In the latter study population, a larger proportion of the 
young stroke patients had severe motor problems, which increases the sensitivity to 
detect a relationship between motor-related variables and QoL in comparison to our 
population. 
Long-term post-stroke cognition
The most prominent finding in our study on cognition long-term after a young stroke was 
the impairment in mental speed in patients compared with controls. Two earlier studies 
described the short-term cognitive performance after young stroke.63, 101 Both studies 
detected deficits in reasoning, language comprehension and verbal memory, working 
memory, the temporary storage of complex information and cognitive flexibility. However, 
only one study described the long term cognitive function after young stroke. Up to 50% 
of the patients had a below average performance. Deficits in processing speed, working 
memory, and attention were most common.52 This is in line with the mental slowness we 
found in our population. 
 Previously, it was assumed that cognitive deficits after a stroke were mainly due to 
strategically localized infarctions. However, in recent studies it became increasingly clear 
that cerebral ischemia, irrespective of its localization, could lead to cognitive deficits. For 
example due to disruption of functional networks of the cortical regions.102, 103 In addition 
to these functional changes, loss of volume of brain structures remote from the infarction 
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such as the hippocampus and it accompanying performance, has been observed.104, 105 A 
possible explanation for these remote effects may be the occurrence of spreading 
depression. Spreading depression is the pervasive failure of brain ion homeostasis that 
transiently interrupts function of intact brain regions, which causes secondary neuronal 
damage and infarct expansion.26 Another possibility could be disconnection of distant 
brain regions due to stroke in the connecting fiber tracts. 26
Determinants of long term functional prognosis
Cognition 
After having shown an impaired cognitive performance even decades after a young 
stroke, we aimed to determine the effect of these cognitive sequelae on the functional 
prognosis after a stroke at young age. The presence of cognitive impairment in any of the 
individual cognitive domains was not related to functional outcome nor to iADL 
performance in the FUTURE cohort. To our knowledge no previous studies exist (including 
those in elderly stroke survivors) that investigated the actual effects of cognitive 
performance on long-term functional outcome. We cannot exclude that cognitive 
function in the first weeks or months after stroke is related to long-term functional 
outcome, since we did not perform a neuropsychological examination in the first period 
after stroke. Both functional outcome and cognitive impairment were assessed on average 
11 years after stroke in a cross-sectional study design.
 The lack of relationship between objective cognitive impairment and functional 
outcome after young stroke is likely caused by the insensitivity of the commonly used 
functional outcome measures, such as the mRS and the iADL questionnaire. The mRS is a 
scale predominantly based on motor function and does not necessarily reflect all aspects 
of every day performance in young stroke patients. Also, the mRS is not a very sensitive 
scale. Despite a wide range of differences in cognitive performance in the healthy 
population, most of them will be independent in daily life, with no variation in mRS scores. 
Although the iADL is more sensitive to detect problems in complex social skills than the 
mRS, it still only involves eight basic daily life tasks. Probably only severe cognitive 
problems would interfere with these tasks. Important aspects of everyday functioning 
that are relevant especially for younger adults, such as vocational performance, academic 
achievements or more complex everyday tasks like computer skills are not covered in this 
scale.
Kidney function 
As a first step in clarifying the relationship between kidney function and the long-termm 
prognosis after young stroke, we have shown that kidney function at stroke onset is 
associated with higher mortality and incident cerebrovascular events after stroke in young 
adults, independent of cardiovascular risk factors. In the elderly population kidney 
dysfunction has been independently associated with increased risk of incident 
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cardiovascular events after stroke.91, 90, 92 One study in young stroke patients, with a 
substantially shorter follow-up, also investigated the relationship between kidney 
dysfunction and incident arterial events in a young stroke population.79 In contrast to our 
results, this association was not independent of cardiovascular risk factors. Very 
interestingly, we could not establish an association between kidney dysfunction and 
other vascular events independent of hypertension, diabetes mellitus and/or a history of 
vascular events. This suggests an additional pathophysiological mechanism underlying 
the association between kidney disease and incident stroke apart from traditional risk 
factors that does not affect other arteries. It could be that kidney dysfunction provokes 
increased blood pressures through several pathophysiological mechanisms,93 possibly 
increasing the risk of vascular events independent of the presence of hypertension at 
baseline. One of the underlying pathophysiological mechanisms is that is has been shown 
that intrarenal chemoreceptors and/or baroreceptors are stimulated in renal disease. Such 
stimulatory activating signals are transmitted through the medulla to the hypothalamus, 
causing increased norepinephrine turnover in the hypothalamus and efferent sympathetic 
nerve traffic, leading to an increased blood pressure. However, this does not provide a 
clear explanation for the increased risk of incident strokes, but not of incident vascular 
events in patients with kidney dysfunction.
 It can be speculated that the heart is less vulnerable to hypertension itself, while the 
brain and kidney share a similar vascular structure with low-resistance exposure of the 
small vessels to highly pulsatile flow and pressure.78 Also, there are hypotheses that novel 
non-traditional risk factors, like chronic inflammation and oxidative stress are involved, 
affecting the cerebral microvasculature.78, 80 
Clinical relevance
Our studies provide important information that can be used to counsel patients who 
survive the initial weeks after stroke and visit the outpatient clinic a few months after the 
event. At a young age, stroke has a major impact on psychological and social functioning, 
especially since these patients are in a period of life in which they are actively involved in 
the community. Consequently, patients find prognostic information on the psychosocial 
consequences related to life after stroke of utmost importance,10 not only for the months 
to come but rather for the decades after their stroke.
 In clinical practice it is important to realise that a substantial part of the patients is not 
independent in daily life years after a stroke at young age. This thesis provides several 
determinants of a poor functional prognosis, which can be used to give patients and their 
relatives information about their future perspectives. This gives them the opportunity to 
make balanced decisions about career moves and family planning. In particular women 
with a severe stroke are at risk for a poor long-term functional outcome. Additional risk 
factors for a poor quality of life are signs of depression and anxiety. Also, the occurrence of 
incident strokes is associated with worse functional outcome, stressing the importance of 
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optimal secondary preventive strategies in this population, including both life style 
changes and drug treatment aimed at reducing cardiovascular risk factors. Finally, it is 
important that treating physicians are aware that post-stroke kidney dysfunction is related 
to a higher risk of long-term mortality and stroke recurrence independent of cardiovascular 
risk factors. This warrants a more intensive follow-up of young stroke patients with signs 
of kidney dysfunction in the early phase. In contrast, no clear and consistent relationship 
is seen between long-term cognitive impairment across the various domains and long- 
term outcome using the conventional scales. However, in the absence of more sensitive 
iADL measures, a neuropsychological evaluation may provide important information 
about cognitive performance that is relevant for more complex everyday activities. 
 Whereas young stroke patients, especially those with minor physical deficits, are 
currently often dismissed from routine follow-up within months to at most a few years 
after their stroke, it seems sensible to organize/facilitate a professional support system 
available for these patients for a much longer period. 
Future perspectives
In this thesis we were able to improve the knowledge on the long-term functional 
prognosis after a stroke at young age and we identified several determinants of a poor 
prognosis. However, ideally, in the future clinicians will have access to an easy to use risk 
model to estimate the prognosis of an individual patient. To be able to provide such 
individualized information it is necessary to have a wide range of reliable baseline 
parameters and to have access to a validation cohort. In addition, increasing knowledge 
on the pathophysiological mechanisms underlying determinants of long-term outcome 
after stroke at young age could lead to the development of new preventive strategies or 
treatment options. 
 For instance, despite the rapidly evolving research in the (young stroke) field it is yet 
unclear why patients with rather similar stroke characteristics, such as stroke localization 
and severity, can have completely different long-term outcomes. It can be hypothesized 
that brain infarction does not only have local effects, but also remote effects, as seems the 
case in the development of cognitive sequelae.102, 103 Another possibility is that the 
frequently present cardiovascular risk factors, such as hypertension and diabetes mellitus, 
do not only effect the brain by the increased stroke risk, but also have more direct effects 
on basic physiological processes in the brain.
 In addition, the interest in sex-specific differences in stroke patients, concerning both 
treatment and prognosis is rising. Further research is needed to clarify the effect of both 
sex-hormone related and non-sex-hormone related differences in the underlying patho-
physiological mechanisms. Large study cohorts are necessary to give more insight in the 
extend of complications of pregnancy and contraceptive use in young women. 
 The ultimate goal would be to develop a validated (in multiple cohorts), easy to use 
risk model that can be used to predict the long-term prognosis of young patients only a 
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few weeks after their stroke. These days, this would probably best be presented as a freely 
available app(lication) for all sorts of electronic devices.
Observational Dutch Young Symptomatic StrokE studY  
As a first step in the development of an individualized risk model, we designed a 
multi-center prospective cohort study on young first-ever TIA, IS and ICH patients (<50 
years): the Observational Dutch Young Symptomatic StrokE studY (ODYSSEY).106 Only 
patients with corresponding lesions and/or evidence of acute arterial occlusion on brain 
imaging are included to avoid misclassification of patients. The objectives of this study are 
to determine the risk of mortality and recurrent vascular events, post-stroke epilepsy, 
cognitive impairment and (vascular) dementia after a young stroke. The influence of a 
young stroke on functional outcome, quality of life and depressive symptoms will also be 
investigated. In addition, we will investigate the prevalence of traditional vascular risk 
factors and the relation between potential acute trigger factors and the occurrence of a 
young stroke. 
 Hopefully the detailed information on both baseline parameters and outcome 
measures, which will be collected in a very large cohort of young stroke patients (up to 
1500 patients), will allow us to extend our knowledge about the role of various determinants 
on the long-term functional outcome. 
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Beroertes zijn wereldwijd de tweede doodsoorzaak en een van de meest voorkomende 
oorzaken van blijvende beperkingen. Volgens de Wereld Gezondheidsorganisatie krijgen 
wereldwijd zo’n 15 miljoen mensen per jaar een beroerte. Hiervan overlijden zo’n 5 miljoen 
patiënten en zo’n 5 miljoen blijven permanent beperkingen ervaren. Het risico op een 
beroerte verdubbelt elke 10 jaar na de leeftijd van 55 jaar, dus logischerwijs treedt 
driekwart van de beroertes op bij patienten boven de 65 jaar. Echter, 1 van de 10 beroertes 
treedt op bij patienten tussen de 18 en 50 jaar. Deze worden beschouwd als ‘beroertes bij 
jonge mensen’.   
 Zo’n beroerte op jonge leeftijd treedt op in een periode van het leven waarin mensen 
in het algemeen een actieve rol hebben in de gemeenschap en waarin veel mensen zich 
richten op hun carrière en hun gezin. Onzekerheid over hun lange termijn functioneren 
kan de keuzes van patiënten ten aanzien van deze belangrijke levensgebeurtenissen 
beïnvloeden. Het is daarom nodig om de kennis over de lange termijn prognose na een 
beroerte op jonge leeftijd te vergroten. Daarnaast is het van belang om belangrijke 
voorspellers van de uitkomst te identificeren. Het gaat daarbij niet alleen om factoren die 
behandeld kunnen worden, maar ook informatie over voorspellers die gebruikt kunnen 
worden om patiënten en hun familie goed te informeren, is van belang. In dit proefschrift 
onderzochten we de lange termijn prognose na een beroerte bij jonge patiënten en 
probeerden te identificeren welke determinanten deze lange termijn prognose het beste 
voorspellen. 
 In hoofdstuk 2 van dit proefschrift wordt beschreven hoe patiënten na een beroerte 
op jonge leeftijd functioneren. In hoofdstuk 2.1 toonden we aan dat zelfs 10 jaar na een 
herseninfarct of hersenbloeding op jonge leeftijd 1 op de 8 overlevers (12.9%) niet 
zelfstandig kon functioneren. Bij TIA-patiënten, die per definitie geen lichamelijke 
restschade hebben, was dit 1 op de 15 overlevers (6.5%). Hoofdstuk 2.2 laat zien dat het 
percentage patiënten dat niet zelfstandig functioneert toeneemt in de loop der jaren. Na 
verlenging van de follow-up duur tot een gemiddelde van 14 jaar, was bijna 1 op de 5 
lange termijn overlevers van een herseninfarct (18.8%) en bijna 1 op de 10 overlevers van 
een TIA (9.8%) niet (meer) zelfstandig. In totaal ging 11.5% van de patiënten achteruit van 
een goede naar een slechte uitkomst tussen het eerste (2009-2011) en het tweede 
(2014-2015) follow-up moment. Daarentegen gingen slechts 1.3% van de patiënten van 
een slechte naar een goede uitkomst. Vrouwen hadden twee- tot driemaal zoveel risico 
op een slechte uitkomst als mannen. Daarnaast was de sterkste voorspeller voor het lange 
termijn functioneren de ernst van de initiële beroerte.
 In hoofdstuk 3 werd de lange termijn kwaliteit van leven besproken na een beroerte 
bij jonge patiënten. Er waren na een lange follow-up (gemiddeld 4.9 jaar) geen 
opmerkelijke verschillen in kwaliteit van leven bij jonge patiënten na een beroerte en 
gezonde controles. Depressie en angst kwamen echter beide veel vaker voor in de jaren 
na een beroerte op jonge leeftijd dan bij controles. Multipele regressie analyse liet zien 
dat vooral vermoeidheid en in mindere mate depressie, angst en werkloosheid een 
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negatieve invloed hadden op de kwaliteit van leven bij patiënten lang na hun beroerte. 
Daarentegen waren variabelen die gerelateerd waren aan de ernst van de beroerte, zoals 
de mate van de neurologische beperkingen bij opname en bij latere beoordeling, niet 
gerelateerd aan de kwaliteit van leven. 
 Hoofdstuk 4 van dit proefschrift beschrijft het voorkomen van lange termijn 
cognitieve beperkingen na een beroerte op jonge leeftijd. We lieten zien dat patiënten 
met een herseninfarct op jonge leeftijd gemiddeld 5 jaar later slechter scoorden dan 
controles op testen van mentale snelheid en in enige mate ook verbaal geheugen.
 In hoofdstuk 5 trachtten we de waarde van potentiële determinanten van een slechte 
uitkomst na een herseninfarct op jonge leeftijd vast te stellen. Hoofdstuk 5.1 laat zien dat 
gemiddeld 11 jaar na een beroerte op jonge leeftijd de aanwezigheid van cognitieve 
stoornissen op de afzonderlijke cognitieve domeinen niet gerelateerd was aan de 
functionele uitkomst, gemeten met twee verschillende schalen (“modified Rankin Scale” 
en “instrumental Activities of Daily Living scale”). In hoofdstuk 5.2 wordt besproken dat 
patiënten met nierfunctiestoornissen ten tijde van hun beroerte een 15-jaars-risico op 
overlijden danwel recidief beroertes hadden van respectievelijk 70% en 45%. Dit risico is 
vier- tot vijfmaal hoger dan patiënten met een normale nierfunctie, onafhankelijk van 
bijkomende hypertensie of diabetes mellitus. Opmerkelijk was dat diezelfde associatie 
niet gezien werd tussen nierfunctiestoornissen ten tijde van een beroerte op jonge 
leeftijd en het optreden van andere vasculaire aandoeningen in de jaren daarna.
Conclusie
Op lange termijn is de functionele prognose van jonge patiënten met een beroerte niet 
gunstig. Dit is tegenstrijdig met de algemene verwachting van neurologen, hetgeen 
voornamelijk gebaseerd is op de studies die het korte termijn overlijdensrisico beschrijven 
in jonge patiënten met een beroerte ten opzichte van oudere patiënten. Een substantieel 
deel van de patiënten is afhankelijk in het dagelijks leven zelfs lang na hun beroerte 
(gemiddeld 14 jaar later), ondanks hun jonge leeftijd.  Dit is vooral het geval bij vrouwen 
en patiënten met ernstige neurologische uitval bij opname. Vermoeidheid en depressie 
na een beroerte zijn geassocieerd met een lagere kwaliteit van leven. Daarom is het 
belangrijk dat zorgprofessionals actief navragen of dergelijke symptomen aanwezig zijn. 
Daarentegen bleek het effect van cognitieve restverschijnselen na een beroerte op het 
dagelijks functioneren minder duidelijk te zijn. Een nieuw inzicht is de associatie tussen 
nierfunctiestoornissen en een verhoogd risico op nieuwe beroertes na een beroerte op 
jonge leeftijd. 
 De resultaten van deze studies bieden zorgprofessionals de kans om deze jonge 
patiënten en hun naasten meer gerichte informatie te geven over de functionele prognose op 
lange termijn na een beroerte. Er zijn meer studies nodig om een individueel prognostisch 
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model te ontwikkelen om jonge patiënten na een beroerte goed te informeren en om de 
specifieke pathofysiologische mechanismes te verduidelijken die verantwoordelijk zijn 
voor de invloed van bepaalde voorspellers op de prognose, zoals het vrouwelijke geslacht 
en nierfunctiestoornissen.  
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A.1 List of abbreviations
ANOVA = analysis of variance
BADS = Behavioral Assessment of the Dysexecutive Syndrome 
CI = confidence interval
CKD-EPI = chronic kidney disease epidemiology collaboration equation
COMPAS-study = COMPlaints After Stroke study
CT = computed tomography imaging
eGFR = estimated Glomerular Filtration Rate
FAS = Fatigue Assessment Scale
FUTURE = Follow-Up of Transient ischemic attack and stroke patients and Unelucidated Risk factor Evaluation
HADS = Hospital Anxiety and Depression Scale
HR = hazard ratio
iADL =  instrumental Acitvities of Daily Living scale
ICH = intracerebral hemorrhage
IQR = interquartile range
IS = ischemic stroke
LACI = lacunar infarction
MANOVA = multivariate analysis of variance
MRI = Magnetic resonance imaging
mRS = modified Rankin Score
NIHSS = National Institute of Health Stroke Scale
OR = odds ratio
PACI = partial anterior circulation infarction
POCI = posterior circulation infarction
PPMST = Paper and Pencil Memory Scanning Task
QoL= Quality of Life
RAVLT = Rey Auditory Verbal Learning Test
ROCF = Rey- Osterrieth Complex Figure
SD = standard deviation
TACI = total anterior circulation infarction
TIA = transient ischemic attack
TOAST = Trial of ORG 10172 in Acute Stroke Treatment classification
VSAT = Verbal Series Attention Task
WHOQOL-BREF 26 = the shortened World Health Organization Quality of Life scale
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traject.  
Dank aan de manuscriptcommissie, Prof. Dr. Geurts, Prof. Dr. Maas en Prof. Dr. Kappelle, 
voor het nauwgezet doorlezen van dit manuscript en jullie deelname aan deze voor 
mij belangrijke dag. Ook de bijdrage van de overige leden van de promotiecommisie 
waardeer ik natuurlijk ten zeerste!
Alle medeauteurs van de manuscripten wil ik hartelijk danken voor hun inzet en intellectuele 
bijdrage aan de verschillende studies in dit proefschrift. 
Beste Marienke, iets wat ooit begon als een onderzoek voor jouw wetenschappelijke 
stage, vormt uiteindelijk een belangrijk onderdeel van mijn promotieboekje. Dank dat je 
me de ruimte gegeven hebt om met jouw data aan de slag te gaan en dank voor de fijne 
samenwerking die uiteindelijk tot twee gezamenlijke publicaties heeft geleid!
Beste Renate en Mayte, in de laatste fase van mijn onderzoeksperiode hebben we het 
toch maar mooi voor elkaar gekregen om nog een follow-up ronde van de FUTURE studie 
compleet te krijgen, met hulp van Jeske en Sharon, een leuke afsluiter! Daarnaast heb ik 
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genoten van de dagelijkse hoogstaande vakinhoudelijke besprekingen. Dank voor de 
leuke herinneringen aan mijn onderzoekstijd!
Beste Loes en Noortje, jullie werk ligt aan de basis van mijn Nijmeegse artikelen, maar ook 
in de afsluitende fase heb ik steeds veel gehad aan jullie gedetailleerde commentaren op 
mijn manuscripten, dank daarvoor!
Alle arts-assistenten neurologie waar ik de laatste jaren mee samengewerkt heb in Tilburg, 
Rotterdam en Nijmegen wil ik bedanken voor de gezellige samenwerking. In het bijzonder 
wil ik Mariet, Bianca en Britta noemen; eerst waren we collega’s die samen gingen sporten, 
inmiddels zijn we uitgegroeid tot een groepje vriendinnen dat elkaar ondanks de uitstapjes 
naar verschillende ziekenhuizen in de afgelopen jaren altijd wist te vinden om bij te praten 
over belangrijke en minder belangrijke zaken. Dank voor de vele gezellige uren die geweest 
zijn en zeker nog gaan komen! 
Onderzoek, opleiding en kinderen… druk dus! Ik wil dan ook al mijn vrienden bedanken, 
die steeds weer begrip hiervoor hadden. Bedankt voor jullie nooit aflatende interesse en 
vertrouwen in de voortgang van dit project, zelfs als ik dat zelf niet zag. 
Lieve Britta, hiervoor werd je al kort even genoemd, maar vanwege je bijzondere rol 
vandaag wil ik je hier nog even extra bedanken. Na de vele uren in de trein naar Rotterdam, 
de oeverloze gesprekken en onze vakantie samen zijn we inmiddels veel meer dan 
gewone collega’s. Maar jij weet ook hoe het is om vanuit Tilburg te gaan promoveren, 
waarbij we als pioniers zelf onze positie moesten uitvinden. Erg fijn om deze bijzondere 
ervaring met iemand te kunnen delen. Ik ben heel erg blij dat je deze dag naast me wil 
staan als paranimf!
Lieve Marjolein, na 6 maanden lang in Israel samen op 10m2 geleefd te hebben gingen 
we jaren later nog eens terug om het gevoel van die tijd terug te halen. Ik hoop dat 
we elkaar kunnen helpen om nog vele jaren dat gevoel van vrijheid en eenvoudig geluk 
vast te houden. Bedankt dat je op deze dag naast mij wil staan als paranimf!
Ria, Linda en Bas, mijn tweede familie, wat fijn om zo’n lief vangnet achter ons te hebben 
staan. Door jullie kunnen wij ons af en toe even opladen om er weer vol tegenaan te gaan. 
Bedankt!
Lieve opa’s, na al jullie eindeloze interesse in mijn opleiding vind ik het heel bijzonder dat 
jullie ook van deze stap kunnen meegenieten!
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Michiel, mijn niet meer zo kleine broertje, dank je voor alle ontspannen uurtjes samen op 
de bank zonder druk of verplichtingen. Je bent altijd welkom!
Lieve papa en mama, ondanks de geografische afstand tussen ons heb ik gevoel dat jullie 
altijd achter me staan. Ook kunnen we altijd bij jullie terecht voor een luxe mini-vakantie, 
heerlijk! Aangezien woorden te kort schieten om jullie te bedanken is dit boekje voor jullie. 
Mama, dankzij jou is dit boekje helemaal af; bedankt dat je de uitnodiging aangenomen 
hebt om de kaft te ontwerpen, het had niet mooier kunnen worden!
Lieve Peter, bedankt dat je precies weet wanneer me rust te gunnen en wanneer me op 
te peppen, samen kunnen we de wereld aan! Iris, Tiemen en Jonas, meer tijd en rust om 
samen de wereld te verkennen. Boekje lezen?
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A.4 Curriculum vitae
Nathalie Synhaeve was born on May 17th, 1984 in Antwerp, Belgium. She attended the 
gymnasium at the Stedelijk Gymnasium in ‘s-Hertogenbosch and graduated cum laude in 
2002. That year she started medical school at the Radboud University of Nijmegen. After 
the regular clerkships Nathalie performed a scientific elective at the Sourasky Medical 
Centre, in Tel Aviv, Israel. Here she worked with prof. Nir Giladi investigating promotor 
manifestations of Parkinson’s disease. After graduation in 2008 she worked 6 months as a 
resident in the Intensive Care department of the St. Elisabeth Hospital, Tilburg. In May 2009 
Nathalie started working as a resident in neurology, also in Tilburg, and started her 
specialisation in January 2010. She hopes to finish her specialisation in 2017. In 2012 she 
started this PhD-project, resulting in this thesis under supervision of Dr. Paul de Kort and 
Dr. Frank-Erik de Leeuw. 
During the past years she has combined research and clinical training. Nathalie is married 
to Peter Bindels. Together they have three children; Iris, Tiemen and Jonas.
Nathalie Synhaeve is geboren op 17 mei 1984 in Antwerpen, België. Zij volgde gymnasium 
aan het Stedelijk Gymnasium in ’s-Hertogenbosch (cum laude). In 2002 begon zij aan haar 
studie geneeskunde aan de Radboud Universiteit Nijmegen. Haar wetenschappelijke 
stage voerde ze uit in het Sourasky Medical Centre in Tel Aviv, Israel. Onder supervisie van 
prof. Nir Giladi deed zij onderzoek naar vroege verschijnselen van de ziekte van Parkinson. 
Na haar artsexamen werkte Nathalie een half jaar als arts-assistent op de Intensive Care 
van het St. Elisabeth Ziekenhuis in Tilburg. Aansluitend ging Nathalie als arts-assistent 
neurologie werken in hetzelfde ziekenhuis, waar ze in januari 2010 begon aan haar 
opleiding tot neuroloog. Zij hoopt de opleiding in 2017 af te ronden. In 2012 begon zij 
daarnaast met haar promotieonderzoek, een gecombineerd Tilburgs-Nijmeegs project, 
onder begeleiding van Dr. Paul de Kort en Dr. Frank-Erik de Leeuw. De afgelopen jaren 
combineerde zij onderzoek en opleiding. Nathalie is getrouwd met Peter Bindels. 
Samen hebben zij drie kinderen; Iris, Tiemen en Jonas.
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A.5 List of publications
Synhaeve NE, Celie F. Monsters; Ideeën uit de late Middeleeuwen over de oorzaak van 
hun misvorming. Geschiedenis der Geneeskunde 2006; 4; 18-24. 
Synhaeve NE, Aerts MB, Mirelman A, Bloem BR, Giladi N, Hausdorff JM. Is heart rate 
variability related to gait impairment in patients with Parkinson’s disease? A pilot study. 
Parkinsonism Relat Disord. 2009;15:712-5. 
Synhaeve NE, Tijssen CC. Een man met bewustzijnsdaling weken na een schedeltrauma. 
Ned Tijdschr Geneeskd. 2011;155:A1722.
Synhaeve NE, de Kort PL, van Kasteren M, Tijssen C. HIV en beroerte. Tijdschrift voor 
neurologie en neurochirurgie 2012;113:52-7. 
Nominated for best publication of 2012 in this journal. 
Synhaeve NE, van der Heul C, Tijssen CC. Intracranial mass of multiple myeloma with 
good response to chemotherapy. BMJ Case Rep. 2012.
Synhaeve NE, Arntz RM, Maaijwee NA, Rutten-Jacobs LC, Schoonderwaldt HC, Dorresteijn 
LD, de Kort PL, van Dijk EJ, de Leeuw FE. Poor long-term functional outcome after stroke 
among adults aged 18 to 50 years: Follow-Up of Transient Ischemic Attack and Stroke 
Patients and Unelucidated Risk Factor Evaluation (FUTURE) study. Stroke 2014;45:1157-1160.
Synhaeve NE, de Bruijn MA, van Rijsbergen MW, de Leeuw FE, Mark RE, Jansen BP, de Kort 
PL. Quality of life after young ischemic stroke of mild severity is mainly influenced by 
psychological factors. Journal of Stroke and Cerebrovascular Diseases 2015;24:2183-2188. 
Arntz RM, van Alebeek ME, Synhaeve NE, Brouwers PJ, van Dijk GW, Gons RA, den Heijer 
T, de Kort PL, de Laat KF, van Norden AG, Vermeer SE, van der Vlugt MJ, Kessels RP, van Dijk 
EJ, de Leeuw FE. Observational Dutch Young Symptomatic StrokE studY (ODYSSEY): study 
rationale and protocol of a multicentre prospective cohort study. BMC Neurology 2014;14.
Synhaeve NE, de Bruijn MA, van Rijsbergen MW, de Leeuw FE, Jansen BP, de Kort PL. 
Long-term cognitive outcome of ischaemic stroke in young adults. Cerebrovascular 
Diseases 2014;37:376-381.
Winner of the ‘van Buchemprijs’ 2015, a price for the best research article in the St. Elisabeth 
hospital in the previous 2 years.
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Synhaeve NE, Schaapsmeerders P, Arntz RM, Maaijwee NA, Rutten-Jacobs LC, 
Schoonderwaldt HC, Dorresteijn LD, de Kort PL, van Dijk EJ, Kessels RPC, de Leeuw FE. 
Cognitive performance and poor long-term functional outcome after young stroke. 
Neurology 2015;85:776-782.
Synhaeve NE, Arntz RM, van Alebeek ME, van Pamelen J, Maaijwee NAM, Rutten-Jacobs 
LCA, Schoonderwaldt HC, de Kort PL, van Dijk EJ, de Leeuw FE.  Women have a poorer very 
long-term functional outcome after stroke among adults aged 18-50 years: the FUTURE 
study.  Journal of Neurology 2016;263:1099-1105.
Synhaeve NE, van Alebeek ME, Arntz RM, Maaijwee NA, Rutten-Jacobs LC, Schoonderwaldt 
HC, de Kort PL, van der Vlugt MJ, van Dijk EJ, Wetzels JFM, de Leeuw FE.  Kidney dysfunction 
increases the risk of mortality and incident vascular events in young stroke patients: 
the FUTURE Study. Cerebrovascular Diseases 2016;42:224-231.
Submitted:
Arntz RM, van Alebeek ME, Synhaeve NE, van Pamelen J, Maaijwee NAMM, Schoonderwaldt 
H, van der Vlugt MJ, van DIJk EJ, Rutten-Jacobs LCA, de Leeuw FE. The very long-term risk 
and predictors of recurrent ischemic events after a stroke at young age: the FUTURE-study. 
Conferences and presentations
Synhaeve NE, van der Heul C, Tijssen CC. Intracraniële uitbreiding van multipel myeloom 
met goede respons op chemotherapie. Poster presentation. Wetenschappelijke vergadering 
Wetenschappelijke vergadering Nederlandse Vereniging voor Neurologie. Garderen, 
the Netherlands, November 3rd-4th, 2012. 
Synhaeve NE, de Bruijn MAAM, van Rijsbergen M, Jansen BPW, de Kort PLM. De gevolgen 
van beroerte bij jonge patiënten. Oral presentation. Wetenschapsdag St. Elisabeth 
ziekenhuis, January 21st, 2013.
Winner best oral presentation
Synhaeve NE, Arntz RM, Maaijwee NAM, Rutten-Jacobs LCA, Schoonderwaldt HC, 
Dorresteijn LDA, de Kort PLM, van Dijk EJ, de Leeuw FE. Poor long-term functional outcome 
after young stroke: the FUTURE study. Poster presentation. European Stroke Conference. 
London, United Kingdom. May 30th, 2013.
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Synhaeve NE, Arntz RM, van Alebeek ME, Brouwers PJ, van Dijk GW, Gons RA, den Heijer 
T, de Kort PL, de Laat KF, van Norden AG, Vermeer SE, van der Vlugt MJ, Kessels RP, 
van Dijk EJ, de Leeuw FE. Cognitief functioneren na een beroerte op jonge leeftijd. Oral 
presentation. Wetenschappelijke vergadering Nederlandse Neurovasculaire Werkgroep. 
Amsterdam, the Netherlands, September 20th 2013. 
Synhaeve NE, de Bruijn MAAM, van Rijsbergen M, Jansen BPW, de Kort PLM. Lange termijn 
prognose van herseninfarcten in jonge volwassenen. Poster presentation. Wetenschappelijke 
vergadering Nederlandse Vereniging voor Neurologie. Garderen, the Netherlands, 
November 8th, 2013. 
Winner best poster presentation.
Synhaeve NE, van Alebeek ME, Arntz RM, Maaijwee NA, Rutten-Jacobs LC, Schoonderwaldt 
HC, de Kort PL, van der Vlugt MJ, van Dijk EJ, Wetzels JFM, de Leeuw FE. Renal dysfunction: 
a new cause for stroke in young adults. Poster presentation. European Stroke Organisation 
Conference.  Glasgow, United Kingdom. April 18th, 2015. 
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A.6  Dissertations of the disorders of  
movement research group, Nijmegen  
Parkinson Center Nijmegen (ParC)
•	 Jasper E. Visser. The basal ganglia and postural control. Radboud University Nijmegen, 17 June 2008
•	 Maaike Bakker. Supraspinal control of walking: lessons from motor imagery. Radboud University Nijmegen, 
27 May 2009
•	 W. Farid Abdo. Parkinsonism: possible solutions to a diagnostic challenge. Radboud University Nijmegen, 
7 October 2009
•	 Samyra H.J. Keus. Physiotherapy in Parkinson’s disease. Towards evidence-based practice. Leiden University, 
29 April 2010
•	 Lars B. Oude Nijhuis. Modulation of human balance reactions. Radboud University Nijmegen, 29 November 2010
•	 Maarten J. Nijkrake. Improving the quality of allied health care in Parkinson’s disease through communi-
ty-based networks: the ParkinsonNet health care concept. Radboud University Nijmegen, 29 November 2010
•	 Rick C.G. Helmich. Cerebral reorganization in Parkinson’s disease. Radboud University Nijmegen, 24 May 2011
•	 Charlotte A. Haaxma. New perspectives on preclinical and early stage Parkinson’s disease. Radboud University 
Nijmegen, 6 December 2011
•	 Johanna G. Kalf. Drooling and dysphagia in Parkinson’s disease. Radboud University Nijmegen, 22 December 2011
•	 Anke H. Snijders. Tackling freezing of gait in Parkinson’s disease. Radboud University Nijmegen,4 June 2012
•	 Bart F.L. van Nuenen. Cerebral reorganization in premotor parkinsonism. Radboud University Nijmegen, 
22 November 2012
•	 Wandana Nanhoe-Mahabier. Freezing of physical activity in Parkinson’s disease, the challenge to change 
behavior. Radboud University Nijmegen, 13 February 2013
•	 Marlies van Nimwegen. Promotion of physical activity in Parkinson’s disease, the challenge to change 
behavior. Radboud University Nijmegen, 6 March 2013
•	 Arlène D. Speelman. Promotion of physical activity in Parkinson’s disease, feasibility and effectiveness. 
Radboud University Nijmegen, 6 March 2013
•	 Tjitske Boonstra. The contribution of each leg to bipedal balance control. University Twente, 6 June 2013
•	 Marjolein A van der Marck. The Many faces of Parkinson’s disease: towards a multifaceted approach? Radboud 
University Nijmegen, 10 January 2014
•	 Katrijn Smulders. Cognitive control of gait and balance in patients with chronic stroke and Parkinson’s disease. 
Radboud University Nijmegen, 21 May 2014
•	 Marjolein B. Aerts. Improving diagnostic accuracy in parkinsonism. Radboud University Nijmegen, 27 June 2014 
•	 Maartje Louter. Sleep in Parkinson’s disease. A focus on nocturnal movements. Radboud University Nijmegen, 
13 February 2015
•	 Frederick Anton Meijer. Clinical Application of Brain MRI in Parkinsonism: From Basic to Advanced Imaging, 
Radboud University Nijmegen, 23 June 2015
•	 Jorik Nonnekes. Balance and gait in neurodegenerative disease: what startle tells us about motor control, 
Radboud University Nijmegen, 2 September 2015
•	 Martijn van der Eijk. Patient-centered care in Parkinson’s disease. Radboud University Nijmegen, 1 December 2015
•	 Ingrid Sturkenboom. Occupational therapy for people with Parkinson’s disease: towards evidence-informed 
care. Radboud University Nijmegen, 11 February 2016
•	 Merel M. van Gilst. Sleep benefit in Parkinson’s disease. Radboud University Nijmegen, 13 April 2016
•	 Arno M. Janssen. Transcranial magnetic stimulation - measuring and modeling in health and disease. Radboud 
University Nijmegen, 2 June 2016
140
Non-Parkinsonian disorders of movement
•	 Sacha Vermeer. Clinical and genetic characterization of autosomal recessive cerebellarataxias. Radboud 
University Nijmegen, 5 April 2012
•	 Susanne T. de Bot. Hereditary spastic paraplegias in the Netherlands. Radboud University Nijmegen, 
20 December 2013
•	 Catherine C.S. Delnooz. Unraveling primary focal dystonia. A treatment update and new pathophysiological 
insights. Radboud University Nijmegen, 7 January 2014
Vascular disorders of movement – The Radboud Stroke centre
•	 Liselore Snaphaan. Epidemiology of post stroke behavioral consequences. Radboud University Nijmegen, 12 
March 2010
•	 Karlijn F. de Laat. Motor performance in individuals with cerebral small vessel disease: an MRI study. Radboud 
University Nijmegen, 29 November 2011
•	 Anouk G.W. van Norden. Cognitive function in elderly individuals with cerebral small vessel disease. An MRI 
study. Radboud University Nijmegen, 30 November 2011
•	 Rob Gons. Vascular risk factors in cerebral small vessel disease. A diffusion tensor imaging study. Radboud 
University Nijmegen, 10 December 2012
•	 Loes C.A. Rutten-Jacobs. Long-term prognosis after stroke in young adults. Radboud University Nijmegen, 14 
April 2014 
•	 Noortje A.M.M. Maaijwee. Long-term neuropsychological and social consequences after stroke in young 
adults. Radboud University Nijmegen, 12 June 2015
•	 Nathalie E. Synhaeve. Determinants of long-term functional prognosis after stroke in young adults. Radboud 
University Nijmegen, 28 September 2016
Neuromuscular disorders of movement
•	 Mireille van Beekvelt. Quantitative near infrared spectroscopy (NIRS) in human skeletal muscle. Radboud 
University Nijmegen, 24 April 2002
•	 Johan Hiel. Ataxia telangiectasia and Nijmegen Breakage syndrome, neurological, immunological and 
genetic aspects. Radboud University Nijmegen, 23 April 2004
•	 Gerald JD Hengstman. Myositis specific autoantibodies, specificity and clinical applications. Radboud 
University Nijmegen, 21 September 2005
•	  M. Schillings. Fatigue in neuromuscular disorders and chronic fatigue syndrome, a neurophysiological 
approach. Radboud University Nijmegen, 23 November 2005
•	  Bert de Swart. Speech therapy in patients with neuromuscular disorders and Parkinson’s disease. Diagnosis 
and treatment of dysarthria and dysphagia. Radboud University Nijmegen, 24 march 2006
•	 J. Kalkman. From prevalence to predictors of fatigue in neuromuscular disorders. The building of a model. 
Radboud University Nijmegen, 31 October 2006
•	 Nens van Alfen. Neuralgicamyotrophy. Radboud University Nijmegen, 1 November 2006
•	 Gea Drost. High-density surface EMG, pathophysiological insights and clinical applications. Radboud 
University Nijmegen, 9 March 2007
•	 Maria Helena van der Linden. Pertubations of gait and balance: a new experimental setup applied to patients 
with CMT type 1a. Radboud University Nijmegen, 6 October 2009
•	 Jeroen Trip. Redefining the non-dystrophic myotonic syndromes. Radboud University Nijmegen, 22 January 
2010
•	 Corinne G.C. Horlings. A weak balance: balance and falls in patients with neuromuscular disorders. Radboud 
University Nijmegen, 1 April 2010
•	 E. Cup. Occupational therapy, physical therapy and speech therapy for persons with neuromuscular diseases, 
an evidence based orientation. Radboud University Nijmegen, 5 July 2011
A
pp
en
di
ce
s
D
is
se
rt
at
io
ns
 o
f t
h
e 
d
is
or
d
er
s 
of
 m
ov
em
en
t 
re
se
ar
ch
 g
ro
up
, N
ijm
eg
en
141
•	 Alide Tieleman. Myotonic dystrophy type 2, a newly diagnosed disease in the Netherlands. Radboud 
University Nijmegen, 15 July 2011
•	 Nicol Voermans. Neuromuscular features of Ehlers-Danlos syndrome and Marfan syndrome. Radboud 
University Nijmegen, 2 September 2011
•	 Allan Pieterse. Referral and indication for occupational therapy, physical therapy and speech- language 
therapy for persons with neuromuscular disorders. Radboud University Nijmegen, 13 February 2012
•	 Bart Smits. Chronic Progressive External Ophthalmoplegia more than meets the eye. Radboud University 
Nijmegen, 5 June 2012
•	 Ilse Arts. Muscle ultrasonography in ALS. Radboud University Nijmegen, 31 October 2012
•	 M. Minis. Sustainability of work for persons with neuromuscular diseases. Radboud University Nijmegen, 13 
November 2013
•	 Willemijn Leen. Glucose transporter – 1 deficiency syndrome. Radboud University Nijmegen, 26 June 2014
•	 Barbara Jansen. Magnetic Resonance Imaging signature of fascioscpulohumeral muscular dystrophy. 
Radboud University Nijmegen. 14 September 2015
•	 Noortje Rijken. Balance and gait in FSHD, relations with individual muscle involvement. Radboud University 
Nijmegen, 8 December 2015
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A.7  Donders Graduate School 
for Cognitive Neuroscience Series
1. Van Aalderen-Smeets, S.I. (2007). Neural dynamics of visual selection. Maastricht University, Maastricht, the 
Netherlands.
2. Schoffelen, J.M. (2007). Neuronal communication through coherence in the human motor system. Radboud 
University Nijmegen, Nijmegen, the Netherlands.
3. De Lange, F.P. (2008). Neural mechanisms of motor imagery. Radboud University Nijmegen, Nijmegen, the 
Netherlands.
4. Grol, M.J. (2008). Parieto-frontal circuitry in visuomotor control. Utrecht University, Utrecht, the Netherlands.
5. Bauer, M. (2008). Functional roles of rhythmic neuronal activity in the human visual and somatosensory system. 
Radboud University Nijmegen, Nijmegen, the Netherlands.
6. Mazaheri, A. (2008). The influence of ongoing oscillatory brain activity on evoked responses and behaviour. 
Radboud University Nijmegen, Nijmegen, the Netherlands.
7. Hooijmans, C.R. (2008). Impact of nutritional lipids and vascular factors in Alzheimer’s disease. Radboud University 
Nijmegen, Nijmegen, the Netherlands.
8. Gaszner, B. (2008). Plastic responses to stress by the rodent urocortinergic Edinger-Westphal nucleus. Radboud 
University Nijmegen, Nijmegen, the Netherlands.
9. Willems, R.M. (2009). Neural reflections of meaning in gesture, language and action. Radboud University 
Nijmegen, Nijmegen, the Netherlands.
10. Van Pelt, S. (2009). Dynamic neural representations of human visuomotor space. Radboud University Nijmegen, 
Nijmegen, the Netherlands.
11. Lommertzen, J. (2009). Visuomotor coupling at different levels of complexity. Radboud University Nijmegen, 
Nijmegen, the Netherlands.
12. Poljac, E. (2009). Dynamics of cognitive control in task switching: Looking beyond the switch cost. Radboud 
University Nijmegen, Nijmegen, the Netherlands.
13. Poser, B.A. (2009). Techniques for BOLD and blood volume weighted fMRI. Radboud University Nijmegen, 
Nijmegen, the Netherlands.
14. Baggio, G. (2009). Semantics and the electrophysiology of meaning. Tense, aspect, event structure. Radboud 
University Nijmegen, Nijmegen, the Netherlands.
15. Van Wingen, G.A. (2009). Biological determinants of amygdala functioning. Radboud University Nijmegen 
Medical Centre, Nijmegen, the Netherlands.
16. Bakker, M. (2009). Supraspinal control of walking: Lessons from motor imagery. Radboud University Nijmegen 
Medical Centre, Nijmegen, the Netherlands.
17. Aarts, E. (2009). Resisting temptation: The role of the anterior cingulate cortex in adjusting cognitive control. 
Radboud University Nijmegen, Nijmegen, the Netherlands.
18. Prinz, S. (2009). Waterbath stunning of chickens – Effects of electrical parameters on the electroencephalogram and 
physical reflexes of broilers. Radboud University Nijmegen, Nijmegen, the Netherlands.
19. Knippenberg, J.M.J. (2009). The N150 of the Auditory Evoked Potential from the rat amygdala: In search for its 
functional significance. Radboud University Nijmegen, Nijmegen, the Netherlands. 
20. Dumont, G.J.H. (2009). Cognitive and physiological effects of 3,4-methylenedioxymethamphetamine (MDMA or 
’ecstasy’) in combination with alcohol or cannabis in humans. Radboud University Nijmegen, Nijmegen, the 
Netherlands. 
21. Pijnacker, J. (2010). Defeasible inference in autism: A behavioral and electrophysiogical approach. Radboud 
University Nijmegen, Nijmegen, the Netherlands.
22. De Vrijer, M. (2010). Multisensory integration in spatial orientation. Radboud University Nijmegen, Nijmegen, the 
Netherlands.
23. Vergeer, M. (2010). Perceptual visibility and appearance: Effects of color and form. Radboud University Nijmegen, 
Nijmegen, the Netherlands.
24. Levy, J. (2010). In cerebro unveiling unconscious mechanisms during reading. Radboud University Nijmegen, 
Nijmegen, the Netherlands.
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25. Treder, M. S. (2010). Symmetry in (inter)action. Radboud University Nijmegen, Nijmegen, the Netherlands.
26. Horlings C.G.C. (2010). A weak balance: Balance and falls in patients with neuromuscular disorders. Radboud 
University Nijmegen, Nijmegen, the Netherlands.
27. Snaphaan, L.J.A.E. (2010). Epidemiology of post-stroke behavioural consequences. Radboud University Nijmegen 
Medical Centre, Nijmegen, the Netherlands.  
28. Dado – Van Beek, H.E.A. (2010). The regulation of cerebral perfusion in patients with Alzheimer’s disease. Radboud 
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